Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amplifon Interim / Quarterly Report 2023

May 10, 2023

4030_ir_2023-05-10_d83bb59e-fe23-42c9-969c-183df031be3b.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Interim Financial Report as at 31 March 2023

PREFACE 4
INTERIM MANAGEMENT REPORT AS AT 31 MARCH 2023 5
HIGHLIGHTS 6
MAIN ECONOMIC AND FINANCIAL FIGURES 7
INDICATORS 9
SHAREHOLDER INFORMATION 11
RECLASSIFIED CONSOLIDATED INCOME STATEMENT 13
RECLASSIFIED CONSOLIDATED BALANCE SHEET 15
CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT 17
INCOME STATEMENT REVIEW 18
BALANCE SHEET REVIEW 29
ACQUISITION OF COMPANIES AND BUSINESSES 39
OUTLOOK 40
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 MARCH 2023 42
CONSOLIDATED STATEMENT OF FINANCIAL POSITION(*) 43
CONSOLIDATED INCOME STATEMENT(*) 45
STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME 46
STATEMENT OF CHANGES IN CONSOLIDATED EQUITY 47
STATEMENT OF CONSOLIDATED CASH FLOWS 49
SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS 50
NOTES 51
2. Impact of the conflict in Ukraine, COVID-19 emergency, and climate change on the
Group's performance and financial position 52
3. Acquisitions and goodwill 53
4. Intangible fixed assets with useful life 55
5. Property, plant, and equipment 56
6. Right-of-use assets 57
7. Share capital 58
8. Net financial position 59
9. Financial liabilities 62
10. Provision for risk and charges 65
11. Lease liabilities 66
12. Revenues from sales and services 66
13. Operating costs, depreciation and impairment, financial income-expenses and taxes 67
14. Performance Stock Grant 68
15. Non-recurring significant events 68
16. Earnings (loss) per share 69
17. Transactions with parents and other related parties 70
18. Contingent liabilities 71
19. Financial risk management 71
20. Translation of foreign companies' financial statements 72
21. Segment reporting 73
22. Accounting policies 78
23. Subsequent events 82
ANNEXES 83
Consolidation scope 83

Declaration of the Executive Responsible for Corporate Accounting Information pursuant to Article 154-bis of Legislative Decree 58/1998 (Consolidated finance act) .................................. 87

Disclaimer

This report contains forward looking statements ("Outlook") relating to future events and the Amplifon Group's operating, economic and financial results. These forecasts, by definition, contain elements of risk and uncertainty, insofar as they are linked to the occurrence of future events and developments. The actual results may be very different with respect to the original forecast due to several factors, the majority of which are out of the Group's control.

PREFACE

This Interim Financial Report as at 31 March 2023 was prepared in accordance with the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) endorsed by the European Union and should be read together with the Group's consolidated financial statements as at and for the year ended 31 December 2022 that includes additional information on the risks and uncertainties that could impact the Group's operating results or its financial position.

INTERIM MANAGEMENT REPORT

AS AT 31 MARCH 2023

HIGHLIGHTS

In the first three months of 2023 Amplifon recorded a significant increase in revenues across all geographies, as well as an improvement in profitability. This result was achieved thanks to a high organic growth significantly superior to the market driven by the effectiveness of the continuous investments made in the business and operating efficiency.

(€ thousands) First three months 2023 First three months 2022
Recurring Total Recurring Total
Economic figures:
Revenues from sales and services 540,251 540,251 495,808 495,808
Gross operating profit (loss) (EBITDA) 123,533 115,641 112,853 109,806
Operating profit (loss) (EBIT) 61,458 53,566 55,204 52,157
Profit (loss) before tax 49,510 41,618 46,760 43,713
Group net profit (loss) 34,885 29,299 32,807 30,613

The first three months of the year closed with:

  • turnover of €540,521 thousand, an increase of 9.0% compared to the first three months of 2022 (+9.3% at constant exchange rates).
  • gross operating margin (EBITDA) of €123,533 thousand, higher than the first three months of 2022 of 9.5% on a recurring basis, with an EBITDA margin of al 22.9% (+0.1 p.p. against the comparison period).
  • Group net profit of €34,885 thousand, higher than €2,078 thousand (+6.3%) compared to first three months of 2022 on a recurring basis.

Net financial debt, without lease liabilities, amounts to €826,351 thousand compared to €829,993 thousand as of 31 December 2022, confirming the Group's ability to generate cash flow. Free cash flow reached a positive €46,301 thousand (€ 53,410 thousand in the first three months of the prior year) after absorbing capital expenditure of €26,625 thousand (€21,080 thousand in the comparison period). This result made it possible to finance cash-outs for acquisitions of €38,799 thousand (€23,855 thousand in the comparison period).

MAIN ECONOMIC AND FINANCIAL FIGURES

(€ thousands) First three months 2023 First three months 2022
Recurring Non
recurring
Total % on
recurring
Recurring Non
recurring
Total % on
recurring
Change %
on
recurring
Economic figures:
Revenues from sales and
services
540,251 - 540,251 100.0% 495,808 - 495,808 100.0% 9.0%
Gross operating profit (loss)
(EBITDA)
123,533 (7,892) 115,641 22.9% 112,853 (3,047) 109,806 22.8% 9.5%
Operating profit (loss)
before the depreciation and
amortization of PPA related
assets (EBITA)
73,407 (7,892) 65,515 13.6% 66,714 (3,047) 63,667 13.5% 10.0%
Operating profit (loss)
(EBIT)
61,458 (7,892) 53,566 11.4% 55,204 (3,047) 52,157 11.1% 11.3%
Profit (loss) before tax 49,510 (7,892) 41,618 9.2% 46,760 (3,047) 43,713 9.4% 5.9%
Group net profit (loss) 34,885 (5,586) 29,299 6.5% 32,807 (2,194) 30,613 6.6% 6.3%
(€ thousands) 03/31/2023 12/31/2022 Change
Financial figures:
Non-current assets 2,890,270 2,874,982 15,288
Net invested capital 2,352,657 2,338,949 13,708
Group net equity 1,046,141 1,038,509 7,632
Total net equity 1,047,292 1,040,350 6,942
Net financial indebtedness 826,351 829,993 (3,642)
Lease liabilities 479,014 468,606 10,408
Total lease liabilities and net financial indebtedness 1,305,365 1,298,599 6,766
(€ thousands) First three months 2023 First three months 2022
Free cash flow 46,301 53,410
Cash flow generated from (absorbed by) business combinations (38,799) (23,855)
(Purchase) sale of other investments and securities - 40
Cash flow provided by (used in) financing activities (1,796) (28,907)
Net cash flow from the period 5,706 688
Effect of exchange rate fluctuations on the net financial position (2,064) 1,927
Net cash flow from the period with changes for exchange rate fluctuations
and discontinued operations
3,642 2,615
  • EBITDA is the operating result before charging amortization, depreciation, impairment of both tangible and intangible fixed assets and the right of use depreciation.
  • EBITA is the operating result before amortization and impairment of customer lists, trademarks, non-competition agreements and other fixed assets arising from business combinations.

  • EBIT is the operating result before financial income and charges and taxes.

  • Free cash flow represents the cash flow of operating and investing activities before the cash flows used in acquisitions and payment of dividends and the cash flows from or used in other financing activities.

INDICATORS

03/31/2023 12/31/2022 03/31/2022
Net financial indebtedness (€ thousands) 826,351 829,993 868,571
Lease liabilities (€ thousands) 479,014 468,606 469,743
Total lease liabilities & net financial indebtedness (€ thousands) 1,305,365 1,298,599 1,338,314
Net equity (€ thousands) 1,047,292 1,040,350 979,532
Group Net Equity (€ thousands) 1,046,141 1,038,509 977,342
Net financial indebtedness/Net Equity 0.79 0.80 0.89
Net financial indebtedness/Group Net Equity 0.79 0.80 0.89
Net financial indebtedness/EBITDA 1.48 1.52 1.64
EBITDA/Net financial expenses 25.74 22.26 28.16
Earnings per share (EPS) (€) 0.13048 0.79570 0.13638
Diluted EPS (€) 0.15535 0.78699 0.13504
EPS (€) adjusted for non-recurring transactions and
amortization/depreciation related to purchase price allocations to tangible
and intangible assets
0.19629 0.97738 0.18443
Group Net Equity per share (€) 4.653 4.625 4.359
Period-end price (€) 31.94 27.820 40.540
Highest price in period (€) 32.19 47.044 47.430
Lowest price in period (€) 25.02 23.250 33.530
Share price/net equity per share 6.864 6.016 9.304
Market capitalization (€ millions) 7,173,10 6,247,18 9,089,26
Number of shares outstanding 224,580,485 224,557,260 224,204,810
  • Net financial indebtedness/net equity is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to total net equity.
  • Net financial indebtedness/Group net equity is the ratio of the net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to the Group's net equity.
  • Net financial indebtedness/EBITDA is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to recurring operations only, based on pro forma figures in case of significant changes to the structure of the Group).
  • EBITDA/net financial expenses ratio is the ratio of EBITDA for the last four quarters (determined with reference to recurring operations only, based on restated figures in case of significant changes to the structure of the Group) to net interest payable and receivable of the same last four quarters.
  • Earnings per share (EPS) is the net profit for the period attributable to the parent's ordinary shareholders divided by the weighted average number of shares outstanding during the period, considering purchases and sales of treasury shares as cancellations or issues of shares, respectively.
  • Diluted earnings per share (EPS) is the net profit for the period attributable to the parent's ordinary shareholders divided by the weighted average number of shares outstanding during the period adjusted for the dilution effect of potential shares. In the calculation of

outstanding shares, purchases and sales of treasury shares are considered as cancellations and issues of shares, respectively.

  • Earnings per share (EPS) adjusted for non-recurring transactions and amortization/depreciation related to purchase price allocations to tangible and intangible assets is the profit for the period from recurring operations attributable to the parent's ordinary shareholders divided by the weighted average number of outstanding shares in the period adjusted to reflect the amortization of purchase price allocations. When calculating the number of outstanding shares, the purchases and sales of treasury shares are considered cancellations and share issues, respectively.
  • Net Equity per share is the ratio of Group equity to the number of outstanding shares.
  • Period-end price is the closing price on the last stock exchange trading day of the period.
  • Highest price and lowest price are the highest and lowest prices from 1 January to the end of the period.
  • Share price/Net equity per share is the ratio of the share closing price on the last stock exchange trading day of the period to net equity per share.
  • Market capitalization is the closing price on the last stock exchange trading day of the period multiplied by the number of outstanding shares.
  • The number of shares outstanding is the number of shares issued less treasury shares.

SHAREHOLDER INFORMATION

Main shareholders

The main Shareholders of Amplifon S.p.A. as at 31 march 2023 are:

Ampliter S.r.l. Treasury shares Market

Shareholder No. of ordinary
shares
% held % of the total
share capital in
voting rights
Ampliter S.r.l. 95,604,369 42.23% 59.27%
Treasury shares 1,808,135 0.80% 0.56%
Market 128,976,116 56.97% 40.17%
Total 226,388,620 (*) 100.00% 100.00%

(*) Number of shares related to the share capital registered with the Company registrar on 31 March 2023.

Pursuant to article 2497 of the Italian Civil Code, Amplifon S.p.A. is not subject to management and coordination either by its direct parent Ampliter S.r.l. or its indirect parent Amplifin S.p.A.

The shares of the parent Amplifon S.p.A. have been listed on the screen-based stock market Euronext Milano (EXM) since 27 June 2001 and since 10 September 2008 in the STAR segment. Amplifon is also included in the FTSE MIB index and in the Stoxx Europe 600 index.

The chart shows the performance of the Amplifon share price and its trading volumes from 30 December 2022 to 31 March 2023.

As at 31 March 2023 market capitalization was €7,173.1 million.

Dealings in Amplifon shares in the screen-based stock market Mercato Telematico Azionario during the period 30 December 2022 – 31 March 2023, showed:

  • average daily value: €20,439,223.93;
  • average daily volume: 727,994 shares;
  • total volume traded of 48,047,522 shares, or 21.4% of the total number of shares comprising the share capital, net of treasury shares.

RECLASSIFIED CONSOLIDATED INCOME STATEMENT

(€ thousands) First three months 2023 First three months 2022
Recurring Non
recurring (*)
Total % on
recurring
Recurring Non
recurring (*)
Total % on
recurring
Change %
on
recurring
Revenues from sales and
services
540,251 - 540,251 100.0% 495,808 - 495,808 100.0% 9.0%
Operating costs (420,070) (7,892) (427,962) -77.7% (384,518) (2,996) (387,514) -77.5% -9.2%
Other income and costs 3,352 - 3,352 0.6% 1,563 (51) 1,512 0.3% 114.5%
Gross operating profit (loss)
(EBITDA)
123,533 (7,892) 115,641 22.9% 112,853 (3,047) 109,806 22.8% 9.5%
Depreciation, amortization
and impairment losses on
non-current assets
(21,989) - (21,989) -4.1% (20,022) - (20,022) -4.0% -9.8%
Right-of-use depreciation (28,137) - (28,137) -5.2% (26,117) - (26,117) -5.3% -7.7%
Operating result before the
amortization and
impairment of PPA related
assets (EBITA)
73,407 (7,892) 65,515 13.6% 66,714 (3,047) 63,667 13.5% 10.0%
PPA related depreciation,
amortization and
impairment
(11,949) - (11,949) -2.2% (11,510) - (11,510) -2.4% -3.8%
Operating profit (loss) (EBIT) 61,458 (7,892) 53,566 11.4% 55,204 (3,047) 52,157 11.1% 11.3%
Income, expenses,
revaluation and adjustments
of financial assets
126 - 126 0.0% 49 - 49 0.0% 157.1%
Net financial expenses (**) (10,417) - (10,417) -1.9% (7,844) - (7,844) -1.7% -32.8%
Exchange differences,
inflation accounting and Fair
Value valuation (**)
(1,657) - (1,657) -0.3% (649) - (649) 0.0% -153.3%
Profit (loss) before tax 49,510 (7,892) 41,618 9.2% 46,760 (3,047) 43,713 9.4% 5.9%
Taxes (14,665) 2,306 (12,359) -2.7% (13,879) 853 (13,026) -2.8% -5.7%
Net profit (loss) 34,845 (5,586) 29,259 6.5% 32,881 (2,194) 30,687 6.6% 6.0%
Profit (loss) of minority
interests
(40) - (40) 0.0% 74 - 74 0.0% -154.1%
Net profit (loss) attributable
to the Group
34,885 (5,586) 29,299 6.5% 32,807 (2,194) 30,613 6.6% 6.3%

(*) See table at page 14 for details of non-recurring transactions.

(**) It is specified that, on the 2022 comparative period, reclassifications between income, expenses and adjustments of financial assets have been made in order to better represent financial information.

The details of the non-recurring transactions, included in the previous tables, are shown below, in particular:

  • On 5 January 2023 the majority shareholder Ampliter S.r.l. ("Ampliter") issued a plan which provides for the one-off assignment, free of charge, of up to a maximum of 500,000 of the Amplifon shares owned by Ampliter, to the CEO.

The shares will be transferred, free of charge, in five tranches, comprising a first tranche of 260,000 shares and subsequent ones of 60,000 shares each.

As a result of this assignment, which was made completely autonomously by Ampliter and does not envisage any cash-out by Amplifon, based on IFRS 2 "Share Based Payments" an estimated one-off notional cost of €13.7 million will be recognized in the income statement, of which €12.4 million in 2023 and €1.3 million in 2024.

The notional cost for the first quarter of €7,294 thousand was recognized as a non-recurring expense at 31 March 2023.

(€ thousands) Q1 2023 Q1 2022
Bay Audio acquisition and integration costs - (1,000)
GAES second phase integration costs (598) (1,047)
Donations to UNHCR for emergency in Ukraine - (1,000)
Notional cost of the Amplifon shares assigned by the shareholder Ampliter to the CEO (7,294) -
Impact of the non-recurring items on EBITDA (7,892) (3,047)
Impact of the non-recurring items on EBIT (7,892) (3,047)
Impact of the non-recurring items on profit before tax (7,892) (3,047)
Impact of the above items on the tax burden for the period 2,306 853
Impact of the non-recurring items on profit from continued operations (5,586) (2,194)
  • €598 thousand were incurred for the second phase of the GAES.

RECLASSIFIED CONSOLIDATED BALANCE SHEET

The reclassified Consolidated Balance Sheet aggregates assets and liabilities according to operating functionality criteria, subdivided by convention into the following three key functions: investments, operations and finance.

(€ thousands) 03/31/2023 12/31/2022 Change
Goodwill 1,755,695 1,754,028 1,667
Customer lists, non-compete agreements, trademarks and location rights 262,806 266,125 (3,319)
Software, licenses, other int.ass., wip and advances 153,536 153,973 (437)
Property, plant, and equipment 197,866 193,415 4,451
Right of use assets 461,732 451,747 9,985
Fixed financial assets (1) 14,915 13,292 1,623
Other non-current financial assets (1) 43,720 42,402 1,318
Total fixed assets 2,890,270 2,874,982 15,288
Inventories 83,637 76,258 7,379
Trade receivables 190,274 192,066 (1,792)
Other receivables 94,576 77,891 16,685
Current assets (A) 368,487 346,215 22,272
Total assets 3,258,757 3,221,197 37,560
Trade payables (315,988) (325,583) 9,595
Other payables (2) (396,508) (360,461) (36,047)
Provisions for risks (current portion) (2,395) (1,663) (732)
Short term liabilities (B) (714,891) (687,707) (27,184)
Net working capital (A) - (B) (346,404) (341,492) (4,912)
Derivative instruments (3) 24,946 24,474 472
Deferred tax assets 86,540 81,780 4,760
Deferred tax liabilities (105,023) (106,683) 1,660
Provisions for risks (non-current portion) (19,734) (19,944) 210
Employee benefits (non-current portion) (8,841) (8,940) 99
Loan fees (4) 4,215 4,508 (293)
Other long-term payables (173,312) (169,736) (3,576)
NET INVESTED CAPITAL 2,352,657 2,338,949 13,708
Shareholders' equity 1,046,141 1,038,509 7,632
Third parties' equity 1,151 1,841 (690)
Net equity 1,047,292 1,040,350 6,942
Long term net financial debt (4) 747,149 807,907 (60,758)
Short term net financial debt (4) 79,202 22,086 57,116
Total net financial debt 826,351 829,993 (3,642)
Lease liabilities 479,014 468,606 10,408
Total lease liabilities & net financial debt 1,305,365 1,298,599 6,766

Notes for reconciling the condensed balance sheet with the statutory balance sheet:

  • (1) "Fixed financial assets" and "Other non-current financial assets" include equity interests valued by using the net equity method, financial assets at fair value through profit and loss and other non-current assets;
  • (2) "Other payables" includes other liabilities, accrued liabilities and deferred income, current portion of liabilities for employees' benefits and tax liabilities;
  • (3) "Derivatives instruments" includes cash flow hedging instruments not included in the item "Net medium and long-term financial indebtedness";
  • (4) The item "loan fees" is presented in the balance sheet as a direct reduction of the short-term and medium/longterm components of the items "financial payables" and "financial liabilities" for the short-term and long-term portions, respectively.

CONDENSED RECLASSIFIED CONSOLIDATED CASH FLOW STATEMENT

The condensed consolidated cash flow statement is a summarized version of the reclassified statement of cash flows set out in the following pages and its purpose is, starting from the EBIT, to detail the cash flows from or used in operating, investing and financing activities.

(€ thousands) First three months 2023 First three months 2022
(EBIT) 53,566 52,157
Amortization, depreciation and write-downs 62,075 57,649
Provisions, other non-monetary items and gain/losses from disposals 16,405 2,869
Net financial expenses (10,846) (7,920)
Taxes paid (19,166) (6,693)
Changes in net working capital (1,150) 2,015
Cash flow provided by (used in) operating activities before repayment of lease
liabilities
100,884 100,077
Repayment of lease liabilities (27,958) (25,587)
Cash flow provided by (used in) operating activities (A) 72,926 74,490
Cash flow provided by (used in) operating investing activities (B) (26,625) (21,080)
Free Cash Flow (A) + (B) 46,301 53,410
Net cash flow provided by (used in) acquisitions (C) (38,799) (23,855)
(Purchase) sale of other investment and securities (D) - 40
Cash flow provided by (used in) investing activities (B+C+D) (65,424) (44,895)
Cash flow provided by (used in) operating activities and investing activities 7,502 29,595
Treasury shares - (29,723)
Derivatives (1,483) -
Other changes in non-current assets (313) 816
Net cash flow from the period 5,706 688
Net financial indebtedness at the beginning of the period (829,993) (871,186)
Effect of exchange rate fluctuations on net financial indebtedness (2,064) 1,927
Changes in net indebtedness 5,706 688
Net financial indebtedness at the end of the period (826,351) (868,571)

The impact of non-recurring transactions on free cash flow in the period is shown in the following table.

(€ thousands) First three months 2023 First three months 2022
Free cash flow 46,301 53,410
Free cash flow generated by non-recurring transactions (see page 38 for details) (1,342) (1,953)
Free cash flow generated by recurring transactions 47,643 55,363

INCOME STATEMENT REVIEW

Consolidated income statement by segment and geographic area

(€ thousands) First three months 2023
EMEA Americas Asia Pacific Corporate Total
Revenues from sales and services 359,707 100,864 79,594 86 540,251
Operating costs (261,166) (78,355) (57,951) (30,490) (427,962)
Other income and costs 883 2,322 98 49 3,352
Gross operating profit (loss) (EBITDA) 99,424 24,831 21,741 (30,355) 115,641
Depreciation, amortization and impairment of
non-current assets
(10,012) (3,156) (3,435) (5,386) (21,989)
Right-of-use depreciation (18,932) (2,671) (5,969) (565) (28,137)
Operating profit (loss) before the
depreciation and amortization of PPA related
assets (EBITA)
70,480 19,004 12,337 (36,306) 65,515
PPA related depreciation, amortization and
impairment
(8,072) (876) (2,980) (21) (11,949)
Operating profit (loss) (EBIT) 62,408 18,128 9,357 (36,327) 53,566
Income, expenses, revaluation and
adjustments of financial assets
126
Net financial expenses (10,417)
Exchange differences, inflation accounting and
Fair Value valuation
(1,657)
Profit (loss) before tax 41,618
Taxes (12,359)
Net profit (loss) 29,259
Profit (loss) of minority interests (40)
Net profit (loss) attributable to the Group 29,299
(€ thousands) First three months 2023 – Only recurring operations
EMEA Americas Asia Pacific Corporate Total
Revenues from sales and services 359,707 100,864 79,594 86 540,251
Gross operating profit (loss) (EBITDA) 100,021 24,831 21,741 (23,060) 123,533
Operating profit (loss) before the depreciation
and amortization of PPA related assets (EBITA)
71,077 19,004 12,337 (29,011) 73,407
Operating profit (loss) (EBIT) 63,005 18,128 9,357 (29,032) 61,458
Profit (loss) before tax - - - - 49,510
Net profit (loss) - - - - 34,845
Net profit (loss) attributable to the Group - - - - 34,885
(€ thousands) First three months 2022
EMEA Americas Asia Pacific Corporate Total
Revenues from sales and services 340,172 84,021 71,462 153 495,808
Operating costs (248,744) (63,357) (53,090) (22,323) (387,514)
Other income and costs 982 6 (41) 565 1,512
Gross operating profit (loss) (EBITDA) 92,410 20,670 18,331 (21,605) 109,806
Depreciation, amortization and impairment
of non-current assets
(9,736) (2,436) (3,448) (4,402) (20,022)
Right-of-use depreciation (18,655) (1,897) (5,004) (561) (26,117)
Operating profit (loss) before the
depreciation and amortization of PPA
related assets (EBITA)
64,019 16,337 9,879 (26,568) 63,667
PPA related depreciation, amortization and
impairment
(7,704) (754) (3,032) (20) (11,510)
Operating profit (loss) (EBIT) 56,315 15,583 6,847 (26,588) 52,157
Income, expenses, revaluation and
adjustments of financial assets
49
Net financial expenses (*) (7,844)
Exchange differences, inflation accounting
and Fair Value valuation (*)
(649)
Profit (loss) before tax 43,713
Tax (13,026)
Net profit (loss) 30,687
Profit (loss) of minority interests 74
Net profit (loss) attributable to the Group 30,613
(€ thousands) First three months 2022 – Only recurring operations
EMEA Americas Asia Pacific Corporate Total
Revenues from sales and services 340,172 84,021 71,462 153 495,808
Gross operating profit (loss) (EBITDA) 93,457 20,670 19,331 (20,605) 112,853
Operating profit (loss) before the
depreciation and amortization of PPA
related assets (EBITA)
65,066 16,337 10,879 (25,568) 66,714
Operating profit (loss) (EBIT) 57,362 15,583 7,847 (25,588) 55,204
Profit (loss) before tax - - - - 46,760
Net profit (loss) - - - - 32,881
Net profit (loss) attributable to the Group - - - - 32,807

(*) It's specified that, on the comparative period 2022, reclassifications between income, expenses and adjustments of financial assets have been made in order to better represent financial information.

Revenues from sales and services

(€ thousands) First three months
2023
First three months
2022
Change Change %
Revenues from sales and
services
540,251 495,808 44,443 9.0%

Consolidated revenues from sales and services amounted to €540,521 thousand in the first three months of 2023, an increase of €44,443 thousand (+9.0%) compared to the same period of the prior year.

The increase against the same period of 2022 is explained for €36,934 thousand (+7.4%) by organic growth and for €9,255 thousand (+1.9%) by acquisitions. The foreign exchange effect was negative for €1,746 thousand (-0.3%).

The performance was extremely positive across all regions: a strong performance was recorded in EMEA, well balanced across the main markets, despite a challenging comparison base; AMERICAS was once again the region posting the highest organic growth; and APAC reported an excellent performance supported by a double-digit organic growth in Australia and China.

The breakdown of revenues from sales and services by geographic area is shown below.

(€ thousands) First three
months
2023
% on Total First three
months
2022
% on Total Change Change % Exchange diff. Change % in
local
currency
EMEA 359,707 66.6% 340,172 68.6% 19,535 5.7% (838) 6.0%
Americas 100,864 18.7% 84,021 16.9% 16,843 20.0% 543 19.4%
Asia Pacific 79,594 14.7% 71,462 14.5% 8,132 11.4% (1,451) 13.4%
Corporate 86 0.0% 153 0.0% (67) -43.8% - -43.8%
Total 540,251 100.0% 495,808 100.0% 44,443 9.0% (1,746) 9.3%

Europe, Middle-East and Africa

(€ thousands) First three months
2023
First three months
2022
Change Change %
Revenues from sales and
services
359,707 340,172 19,535 5.7%

Consolidated revenues from sales and services amounted to €359,707 thousand in the first three months of 2023, an increase of €19,535 thousand (+5.7%) compared to the same period of the prior year, of which €17,095 thousand (+5.0%) is attributable to organic growth which was particularly significant in Italy and Germany, while a sequential recovery is recorded in Spain and France compared to the last quarter of 2022, even though the French market was still affected by the difficult comparison base due to the hearing healthcare reform anniversary.

Acquisitions contributed €3,278 thousand (+1.0%), while the foreign exchange effect was negative for €838 thousand (-0.3%).

Americas
First three months
First three months
Change
Change %
(€ thousands)
2023
2022
Revenues from sales and
services
100,864 84,021 16,843 20.0%

Consolidated revenues from sales and services amounted to €100,864 thousand in the first three months of 2023, an increase of €16,843 thousand (+20.0%).

The increase is explained for €10,917 thousand (+13.0%) by organic growth, driven mainly by the outstanding performance of Miracle-Ear and Amplifon Hearing Health Care. Acquisitions contributed €5,383 thousand (+6.4%), while the foreign exchange effect was positive for €543 thousand (+0.6%).

In addition to the excellent performance reported in the United States, there was also a significant double-digit growth in Latin America.

Asia Pacific

(€ thousands) First three months
2023
First three months
2022
Change Change %
Revenues from sales and
services
79,594 71,462 8,132 11.4%

Consolidated revenues from sales and services amounted to €79,594 thousand in the first three months of 2023, an increase of €8,132 thousand (+11.4%) compared to the same period in 2022 explained primarily, for by organic growth of €8,989 thousand (+12.6%), driven mainly by Australian and Chinese markets. The Chinese market in particular, posted a strong recovery in the wake of the lockdowns which had negatively impacted all of 2022.

Acquisitions contributed €594 thousand (+0.8%) and is attributable entirely to acquisitions in China. The foreign exchange effect was negative for €1,451 thousand (-2.0%).

Gross operating profit (EBITDA)

(€ thousands) First three months 2023 First three months 2022
Non
Recurring
Total
recurring
Recurring Non
recurring
Total
Gross operating profit (loss) (EBITDA) 123,533 (7,892) 115,641 112,853 (3,047) 109,806

Gross operating profit (EBITDA) amounted to €115,641 thousand in the first three months of 2023, an increase of €5,835 thousand (+5.3%) with respect to the comparison period. The EBITDA margin came to 21.4%, 0.7 p.p. lower than in the comparison period.

The result for the reporting period reflects non-recurring expenses of €7,892 thousand. More in detail:

  • for €7,294 thousand, by the notional cost of the free of charge, one-off assignment made by the shareholder Ampliter of 500,000 of its Amplifon shares to the CEO Enrico Vita, recognized in the reporting period in accordance with IFRS 2 "Share Based Payments". For more information refer to note 14 of this report;
  • €598 thousand were incurred for the second phase of the GAES.

In the first three months of 2022 non-recurring expenses of €3,047 thousand were also incurred.

Net of these items, EBITDA would have been €10,680 thousand (+9.5%) higher than in the first three months of 2022 with an increase in the EBITDA margin of +0.1 p.p.

(€ thousands) First three
months 2023
EBITDA Margin First three
months 2022
EBITDA
Margin
Change Change %
EMEA 99,424 27.6% 92,410 27.2% 7,014 7.6%
Americas 24,831 24.6% 20,670 24.6% 4,161 20.1%
Asia Pacific 21,741 27.3% 18,331 25.7% 3,410 18.6%
Corporate (*) (30,355) -5.6% (21,605) -4.4% (8,750) -40.5%
Total 115,641 21.4% 109,806 22.1% 5,835 5.3%

The breakdown of EBITDA by geographic region is shown below.

(*) Centralized costs are shown as a percentage of the Group's total sales.

The table below shows the breakdown of the EBITDA by geographic area with reference to the recurring operations.

(€ thousands) First three
months 2023
EBITDA Margin First three
months 2022
EBITDA
Margin
Change Change %
EMEA 100,021 27.8% 93,457 27.5% 6,564 7.0%
Americas 24,831 24.6% 20,670 24.6% 4,161 20.1%
Asia Pacific 21,741 27.3% 19,331 27.1% 2,410 12.5%
Corporate (*) (23,060) -4.3% (20,605) -4.2% (2,455) -11.9%
Total 123,533 22.9% 112,853 22.8% 10,680 9.5%

(*) Centralized costs are shown as a percentage of the Group's total sales.

Europe, Middle East and Africa

Gross operating profit (EBITDA) amounted to €99,424 thousand in the first three months of 2023, an increase of €7,014 thousand (+7.6%) with respect to the comparison period. The EBITDA margin came to 27.6%, 0.4 p.p. higher than in the first three months of 2022.

The result for the reporting period reflects non-recurring expenses of €598 thousand attributable to the second phase of the GAES integration.

In the first three months of 2022 non-recurring expenses of €1.047 thousand.

Net of this item, EBITDA would have been €6,564 thousand (+7.0%) higher than in the first three months of 2022 with the EBITDA margin up +0.3 p.p.

Americas

Gross operating profit (EBITDA) amounted to €24,831 thousand in the first three months of 2023, an increase of €4,161 thousand (+20.1%) with respect to the comparison period. The EBITDA margin came to 24.6%, in line with the first three months of 2022.

Asia Pacific

Gross operating profit (EBITDA) amounted to €21,741 thousand in the first three months of 2023, an increase of €3,410 thousand (+18.6%) with respect to the comparison period. The EBITDA margin came to 27.3%, 1.6 p.p. higher than in the comparison period. In the first three months of 2022 non-recurring expenses of €1,000 thousand were incurred. Net of this item, EBITDA would have been €2,410 thousand higher (+12.5%) with the EBITDA margin up +0.2 p.p.

Corporate

In the first three months of 2023 the net cost of centralized corporate functions (corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8 amounted to €30,355 thousand (-5.6% EBITDA margin), a change of €8,750 thousand (+40.5%) with respect to the same period of the prior year. The EBITDA margin came to -4.4% in the comparison period.

The result for the reporting period reflects the non-recurring expense for €7,294 thousand stemming from the notional cost of the free of charge, one-off assignment made by the shareholder Ampliter of 500,000 of its Amplifon shares to CEO Enrico Vita recognized in the first quarter in accordance with IFRS 2 "Share Based Payments". For more information refer to section 14 of this report.

In the first three months of 2022 non-recurring expenses of €1,000 thousand were recognized. Net of these items, costs would have been €2,455 thousand (11.9%) higher than in the first three months of 2022 and the margin would have been 0.1 p.p. lower

Operating profit (EBIT)

(€ thousands) First three months 2023 First three months 2022
Recurring Non
recurring
Total Recurring Non
recurring
Total
Operating profit (loss) (EBIT) 61,458 (7,892) 53,566 55,204 (3,047) 52,157

Operating profit (EBIT) amounted to €53,566 thousand in the first three months of 2023, an increase of €1,409 thousand (+2.7%) with respect to the comparison period.

The EBIT margin came to 9.9%, a decrease of 0.6 p.p. against the comparison period.

The result was impacted for €7,892 thousand by the same non-recurring expenses described in the section on EBITDA. The first three months of 2022 were also impacted by non-recurring expenses of €3,047 thousand. Net of these items, EBIT would have been €6,254 thousand higher (+11.3%) compared to the first three months of 2022, with the EBIT margin rising +0.3 p.p..

With respect to the gross operating profit (EBITDA), EBIT was also impacted by higher depreciation and amortization as a result of the opening of new stores, investments in IT systems, as well as higher amortization for right-of-use assets and Purchase Price Allocation.

(€ thousands) First three
months 2023
EBIT Margin First three
months 2022
EBIT Margin Change Change %
EMEA 62,408 17.3% 56,315 16.6% 6,093 10.8%
Americas 18,128 18.0% 15,583 18.5% 2,545 16.3%
Asia Pacific 9,357 11.8% 6,847 9.6% 2,510 36.7%
Corporate (*) (36,327) -6.7% (26,588) -5.4% (9,739) -36.6%
Total 53,566 9.9% 52,157 10.5% 1,409 2.7%

The breakdown of EBIT by geographic area is shown below.

(*) Centralized costs are shown as a percentage of the Group's total sales.

The breakdown of EBIT by geographic area with reference to recurring operations is shown below.

(€ thousands) First three
months 2023
EBIT Margin First three
months 2022
EBIT Margin Change Change %
EMEA 63,005 17.5% 57,362 16.9% 5,643 9.8%
Americas 18,128 18.0% 15,583 18.5% 2,545 16.3%
Asia Pacific 9,357 11.8% 7,847 11.0% 1,510 19.2%
Corporate (*) (29,032) -5.4% (25,588) -5.2% (3,444) -13.5%
Total 61,458 11.4% 55,204 11.1% 6,254 11.3%

(*) Centralized costs are shown as a percentage of the Group's total sales.

Europa, Middle East, Africa

Operating profit (EBIT) amounted to €62,408 thousand in the first three months of 2023, an increase of €6,093 thousand (+10.8%) with respect to the comparison period. The EBIT margin came to 17.3% (+0.7 p.p. against the first three months of 2022).

The result was impacted for €598 thousand by the same non-recurring expenses described in the section on EBITDA. The first three months of 2022 were also affected by non-recurring expenses of €1,047 thousand.

Net of these items, EBIT would have been €5,643 thousand higher (+9.8%) compared to the first three months of 2022, with the EBIT margin up +0.6 p.p..

Americas

Operating profit (EBIT) amounted to €18,128 thousand in the first three months of 2023, an increase of €2,545 thousand (+16.3%) with respect to the comparison period. The EBIT margin came to 18.0%, 0.5 p.p. lower than in the first three months of 2022. The increase in EBIT was largely in line with the growth seen in EBITDA.

Asia Pacific

Operating profit (EBIT) amounted to €9,357 thousand in the first three months of 2023, an increase of €2,510 thousand (+36.7%) with respect to the comparison period. The EBIT margin came to 11.8%, 2.2 p.p. higher than in the first three months of 2022. In the first three months of 2022 non-recurring expenses of €1,000 thousand were incurred.

Net of this item, EBIT would have been €1,510 thousand higher (+19.2%) with the EBIT margin up +0.8 p.p..

Corporate

The net Corporate costs at the EBIT level amounted to €36,327 thousand in the first three months of 2023 (6.7% of the revenues generated by the Group's sales and services), a change of €9,739 thousand.

The result was impacted for €7,294 thousand by the non-recurring expenses described in the section on EBITDA. The first three months of 2022 were also impacted by non-recurring expenses which amounted to €1,000 thousand.

Net of these items, the costs would have been €3,444 thousand (+13.5%) higher.

Profit before taxes

(€ thousands) First three months 2023 First three months 2022
Recurring Non
recurring
Total Recurring Non
recurring
Total
Profit before taxes 49,510 (7,892) 41,618 46,760 (3,047) 43,713

Profit before tax amounted to €41,618 thousand in the first three months of 2023, a decrease of €2,095 thousand (-4.8%) against the comparison period, with a gross profit margin of 7.7% (- 1.1 p.p. with respect to the comparison period).

The result for the reporting period was impacted for €7,892 thousand by the same non-recurring expenses described in the section on EBITDA. In the first three months of 2022 non-recurring expenses of €3,047 thousand were incurred.

On a recurring basis, there would have been an increase of €2,750 thousand (+5.9%) against the first three months of 2022, with the profit margin down 0.3 p.p..

The increase, on recurring basis, compared to the same period of 2022 is due to the strong revenue growth and the solid operational efficiency. This result reflects a €3.5 million increase in net financial expenses mainly due higher interest rates on short-term credit lines (most of the medium/long-term debt is fixed rate) and exchange differences tied to currency volatility mainly in countries in North and South America.

Group net profit

(€ thousands) First three months 2023 First three months 2022
Recurring Non
recurring
Total Recurring Non
recurring
Total
Group net profit 34,885 (5,586) 29,299 32,807 (2,194) 30,613

The Group's net profit came to €29,299 thousand in the first three months of 2023, a decrease of €1,314 thousand (-4.3%) against the comparison period, with a profit margin of 5.4% (-0.8 p.p. against the comparison period).

The result for the reporting period was impacted for €5,586 thousand by the same non-recurring expenses described in the section on EBITDA, net of the tax effect. In the first three months of 2022 non-recurring expenses amounted to €2,194 thousand.

On a recurring basis, there would have been an increase of €2,078 thousand (+6.3%) with respect to the first three months of 2022, with the profit margin down 0.2 p.p..

The tax rate was 29.7% in the reporting period compared to 29.8% in the first three months of 2022.

BALANCE SHEET REVIEW

Consolidated balance sheet by geographical area (*)

(€ thousands) 03/31/2023
EMEA Americas Asia Pacific Eliminations Total
Goodwill 928,253 224,073 603,369 - 1,755,695
Non-competition agreements,
trademarks, customer lists and lease
rights
183,158 23,323 56,325 - 262,806
Software, licenses, other intangible fixed
assets, fixed assets in progress and
advances
113,763 31,248 8,525 - 153,536
Property, plant, and equipment 142,337 22,072 33,457 - 197,866
Right-of-use assets 368,629 38,521 54,582 - 461,732
Financial fixed assets 3,830 10,880 205 - 14,915
Other non-current financial assets 39,646 2,411 1,663 - 43,720
Non-current assets 1,779,616 352,528 758,126 - 2,890,270
Inventories 67,895 6,018 9,724 - 83,637
Trade receivables 192,759 33,358 25,285 (61,128) 190,274
Other receivables 75,260 13,095 6,417 (196) 94,576
Current assets (A) 335,914 52,471 41,426 (61,324) 368,487
Operating assets 2,115,530 404,999 799,552 (61,324) 3,258,757
Trade payables (278,258) (58,609) (40,249) 61,128 (315,988)
Other payables (319,351) (39,575) (37,778) 196 (396,508)
Provisions for risks and charges (current
portion)
(1,685) (710) - - (2,395)
Current liabilities (B) (599,294) (98,894) (78,027) 61,324 (714,891)
Net working capital (A) - (B) (263,380) (46,423) (36,601) - (346,404)
Derivative instruments 24,946 - - - 24,946
Deferred tax assets 65,681 10,115 10,744 - 86,540
Deferred tax liabilities (61,782) (25,519) (17,722) - (105,023)
Provisions for risks and charges (non
current portion)
(17,541) (771) (1,422) - (19,734)
Liabilities for employees' benefits (non
current portion)
(7,927) (214) (700) - (8,841)
Loan fees 4,215 - - - 4,215
Other non-current liabilities (154,787) (16,234) (2,291) - (173,312)
NET INVESTED CAPITAL 1,369,041 273,482 710,134 - 2,352,657
Group net equity 1,046,141
Minority interests 1,151
Total net equity 1,047,292
Net medium and long-term financial
indebtedness
747,149
Net short-term financial indebtedness 79,202
Total net financial indebtedness 826,351
Lease liabilities 380,476 41,368 57,171 - 479,014
Total lease liabilities & net financial
indebtedness
1,305,365
NET EQUITY, LEASE LIABILITIES AND NET
FINANCIAL INDEBTEDNESS
2,352,657

(*) The balance sheet items are analyzed by the Chief Executive Officer and the Top Management by geographical area without separation of the Corporate structures that are natively included in EMEA.

(€ thousands) 12/31/2022
EMEA Americas Asia Pacific Eliminations Total
Goodwill 921,163 213,816 619,049 - 1,754,028
Non-competition agreements,
trademarks, customer lists and lease
rights
185,759 22,022 58,344 - 266,125
Software, licenses, other intangible fixed
assets, fixed assets in progress and
advances
112,883 31,881 9,209 - 153,973
Property, plant, and equipment 136,721 21,006 35,688 - 193,415
Right-of-use assets 366,243 34,242 51,262 - 451,747
Financial fixed assets 3,706 9,378 208 - 13,292
Other non-current financial assets 38,589 2,322 1,491 - 42,402
Non-current assets 1,765,064 334,667 775,251 - 2,874,982
Inventories 60,417 5,781 10,060 - 76,258
Trade receivables 211,132 46,331 28,617 (94,014) 192,066
Other receivables 64,120 8,520 5,450 (199) 77,891
Current assets (A) 335,669 60,632 44,127 (94,213) 346,215
Operating assets 2,100,733 395,299 819,378 (94,213) 3,221,197
Trade payables (310,412) (68,611) (40,574) 94,014 (325,583)
Other payables (284,580) (35,345) (40,735) 199 (360,461)
Provisions for risks and charges (current
portion)
(975) (688) - - (1,663)
Current liabilities (B) (595,967) (104,644) (81,309) 94,213 (687,707)
Net working capital (A) - (B) (260,298) (44,012) (37,182) - (341,492)
Derivative instruments 24,474 - - - 24,474
Deferred tax assets 60,867 10,206 10,707 - 81,780
Deferred tax liabilities (61,419) (26,053) (19,211) - (106,683)
Provisions for risks and charges (non
current portion)
(17,712) (787) (1,445) - (19,944)
Liabilities for employees' benefits (non
current portion)
(8,024) (202) (714) - (8,940)
Loan fees 4,508 - - - 4,508
Other non-current liabilities (151,723) (15,718) (2,295) - (169,736)
NET INVESTED CAPITAL 1,355,737 258,101 725,111 - 2,338,949
Group net equity 1,038,509
Minority interests 1,841
Total net equity 1,040,350
Net medium and long-term financial
indebtedness
807,907
Net short-term financial indebtedness 22,086
Total net financial indebtedness 829,993
Lease liabilities 377,981 36,822 53,803 - 468,606
Total lease liabilities & net financial
indebtedness
1,298,599
NET EQUITY, LEASE LIABILITIES AND NET
FINANCIAL INDEBTEDNESS
2,338,949

Non-current assets

Non-current assets amounted to €2,890,270 thousand at 31 March 2023, an increase of €15,288 thousand respect to the €2,874,982 thousand recorded at 31 December 2022.

The changes in the period are explained (i) for €28,517 thousand by capital expenditure; (ii) for €39,623 thousand by the recognition of right-of-use assets acquired in the period; (iii) for €41,890 thousand by acquisitions made in the reporting period; (iv) for €62,184 thousand by depreciation, amortization and impairment which includes the amortization of the above rightof-use assets; (v) for €32,558 thousand by other net decreases relating primarily to negative foreign exchange differences.

(€ thousands) 03/31/2023 12/31/2022 Change
Goodwill 928,253 921,163 7,090
Non-competition agreements, trademarks, customer lists and
lease rights
183,158 185,759 (2,601)
Software, licenses, other intangible fixed assets, fixed assets in
progress and advances
113,763 112,883 880
EMEA Tangible assets 142,337 136,721 5,616
Right-of-use assets 368,629 366,243 2,386
Financial fixed assets 3,830 3,706 124
Other non-current financial assets 39,646 38,589 1,057
Non-current assets 1,779,616 1,765,064 14,552
Goodwill 224,073 213,816 10,257
Non-competition agreements, trademarks, customer lists and
lease rights
23,323 22,022 1,301
Software, licenses, other intangible fixed assets, fixed assets in
progress and advances
31,881 (633)
Americas Tangible assets 22,072 21,006 1,066
Right-of-use assets 38,521 34,242 4,279
Financial fixed assets 10,880 9,378 1,502
Other non-current financial assets 2,411 2,322 89
Non-current assets 352,528 334,667 17,861
Goodwill 603,369 619,049 (15,680)
Non-competition agreements, trademarks, customer lists and
lease rights
56,325 58,344 (2,019)
Software, licenses, other intangible fixed assets, fixed assets in
progress and advances
8,525 9,209 (684)
Asia Pacific Tangible assets 33,457 35,688 (2,231)
Right-of-use assets 54,582 51,262 3,320
Financial fixed assets 205 208 (3)
Other non-current financial assets 1,663 1,491 172
Non-current assets 758,126 775,251 (17,125)
Total 2,890,270 2,874,982 15,288

The following table shows the breakdown of non-current assets by geographical segment.

Europe, Middle-East and Africa

Non-current assets amounted to €1,779,616 thousand at 31 March 2023, an increase of €14,552 thousand against the €1,765,064 thousand recorded at 31 December 2022. This increase is explained:

  • for €21,795 thousand, by right-of-use assets acquired in the year as a result of the renewal of existing leases and network expansion.
  • for €13,101 thousand, by acquisitions made in the reporting period;
  • for €13,907 thousand, by investments in plant, property and equipment, relating primarily to the opening of new stores and the renewal of existing ones, as well as the purchase of hardware needed to implement Group Information Technology projects detailed below;
  • for €8,418 thousand, by investments in intangible assets, relating to the ongoing implementation and standardization of the Group ERP cloud system for back-office functions (Human Resources, Procurement, Administration and Finance), as well as new front office solutions for the hyper-personalization of customer experiences;
  • for €43,098 thousand, by amortization and depreciation, including amortization of the rightof-use assets referred to above;
  • for €429 thousand, by other increases.

Americas

Non-current assets amounted to €352,528 thousand at 31 March 2023, an increase of €17,861 thousand against the €334,667 thousand recorded at 31 December 2022. This increase is explained:

  • for €19,504 thousand, by acquisitions made in the reporting period;
  • for €6,950 thousand, by right-of-use assets acquired during the year as a result of the renewal of existing leases and network expansion;
  • for €2,823 thousand, by investments in property, plant and equipment, relating to the opening of stores, and the renewal of existing ones.
  • for €2,139 thousand, by investments in intangible assets relating mainly to the development of front office IT systems, primarily at US subsidiaries;
  • for €6,702 thousand, by amortization and depreciation, including the amortization of the right-of-use assets referred to above;
  • for €6,853 thousand, by other negative variations relating primarily to negative foreign exchange differences.

Asia Pacific

Non-current assets amounted to €758,126 thousand at 31 March 2023, a decrease of €17,125 thousand against the €775,251 thousand recorded at 31 December 2022. This variation is explained:

  • for €10,878 thousand, by right-of-use assets acquired during the year as a result of the renewal of existing leases and network expansion, relating primarily to the Australian subsidiaries and, to a lesser degree, the Chinese ones;
  • for €9,285 thousand, by acquisitions made in the reporting period;

  • for €980 thousand, by investments in property, plant and equipment, relating mainly to the opening of stores and the renewal of existing ones, as well as the purchase of the hardware needed to implement IT projects;

  • for €250 thousand, by investments in intangible assets;
  • for €12,384 thousand, by amortization and depreciation, including the amortization of the right-of-use assets referred to above;
  • for €26,134 thousand, by other decreases relating to negative exchange differences which mainly affected the goodwill of companies in Asia Pacific.

Net invested capital

Net invested capital amounted to €2,352,657 thousand at 31 March 2023, an increase of €13,708 thousand against the €2,338,949 thousand recorded at 31 December 2022.

This increase is attributable mainly to the change in non-current assets described above, as well as a decrease in working capital.

The breakdown of net invested capital by geographical region is shown below.

(€ thousands) 03/31/2023 12/31/2022 Change
EMEA 1,369,041 1,355,737 13,304
Americas 273,482 258,101 15,381
Asia Pacific 710,134 725,111 (14,977)
Total 2,352,657 2,338,949 13,708

Europe, Middle East and Africa

Net invested capital came to €1,369,041 thousand at 31 March 2023, an increase of €13,304 thousand against the €1,355,737 thousand recorded at 31 December 2022.

The increase in non-current assets described above was partially offset by a decrease in working capital.

Factoring without recourse in the period involved trade receivables with a face value of €26,251 thousand (€18,433 thousand in the same period of the prior year).

Americas

Net invested capital came to €273,482 thousand at 31 March 2023, an increase of €15,381 thousand against the €258,101 thousand recorded at 31 December 2022.

The increase in non-current assets described above was partially offset by a decrease in working capital.

Factoring without recourse in the period involved trade receivables with a face value of €160 thousand.

Asia Pacific

Net invested capital came to €710,134 thousand at 31 March 2023, a decrease of €14,977 thousand against the €725,111 thousand recorded at 31 December 2022.

The change in non-current assets described above was offset slightly by an increase in deferred tax liabilities.

Factoring without recourse in the period involved trade receivables with a face value of €1,845 thousand.

(€ thousands) 03/31/2023 12/31/2022 Change
Net medium and long-term financial indebtedness 747,149 807,907 (60,758)
Net short-term financial indebtedness 273,813 251,708 22,105
Cash and cash equivalents (194,611) (229,622) 35,011
Net financial indebtedness (A) 826,351 829,993 (3,642)
Lease liabilities – current portion 105,540 99,716 5,824
Lease liabilities – non-current portion 373,474 368,890 4,584
Lease liabilities (B) 479,014 468,606 10,408
Total lease liabilities & net financial indebtedness (A+B) (C) 1,305,365 1,298,599 6,766
Group net equity (D) 1,046,141 1,038,509 7,632
Minority interests 1,151 1,841 (690)
Net Equity (E) 1,047,292 1,040,350 6,942
Financial indebtedness/Group net equity (A/D) 0.79 0.80
Financial indebtedness/Net equity (A/E) 0.79 0.80
Financial indebtedness/EBITDA (*) 1.48 1.52

Net financial position

(*) Net financial indebtedness/EBITDA is the ratio of net financial indebtedness, excluding lease liabilities and short-term investments not cash equivalents, to EBITDA for the last four quarters (determined with reference to recurring operations only, based on pro forma figures in case of significant changes to the structure of the Group).

Excluding lease liabilities net financial debt amounted to €826,351 thousand at 31 March 2023, a decrease of €3,642 thousand compared to 31 December 2022.

The Group confirmed excellent cash generation in the first three months of 2023, with free cash flow reaching a positive €46,301 thousand, slightly lower than in the same period of the prior year (€53,410 thousand) due to higher capital expenditure (€26,625 thousand in the first quarter of 2023 vs. €21,080 thousand in the first quarter of the prior year). This result made it possible to finance €38,799 thousand in acquisitions (€23,855 thousand in the comparison period).

At the end of January 2023 the entire Private Placement 2013-2025 was repaid in advance (€85,371 thousand at the hedging rate).

At 31 March 2023, the Group had cash and cash equivalents, as well as other liquid investments, of €194,611 thousand compared to financial indebtedness of €1,021 million, net of lease liabilities.

Long-term debt amounts to €747,149 thousand, €5,490 thousand of which refers to the longterm portion of deferred payments for acquisitions. The decrease in the period of €60,758 thousand is attributable mainly to the reclassification of portions of bank debt from long- to short-term debt (expiring in the next 12 months).

The short-term debt was about €22,105 thousand higher, coming in at €273,813 thousand. The short-term portion refers primarily to the short-term portion of long-term bank debt (€172,895 thousand), the hot money accounts used to support treasury activities and other short-term credit lines (€79,959 thousand), the interest payable on the Eurobond (€514 thousand) and on

other bank loans (€3,740 thousand) and, lastly, the best estimate of the deferred payments for acquisitions (€16,417 thousand).

The chart below shows the debt maturities compared to the €195 million in available cash and cash equivalents and the unutilized portions of irrevocable credit lines which amount to €255 million, as well as the €148 million in other uncommitted credit lines. The total liquidity includes quotas in low-risk money market funds managed by top-tier financial institutions for €50 million.

Interest payable on financial indebtedness amounted to €6,262 thousand at 31 March 2023, €4,699 thousand at 31 March 2022.

Interest payable on leases recognized in accordance with IFRS 16 amounted to €3,263 thousand versus €2,736 thousand at 31 March 2022.

Interest receivable on bank deposits are €310 thousand at 31 March 2023 versus €39 thousand at 31 March 2022.

The reasons for the changes in net indebtedness are described in the next section on the statement of cash flows.

CASH FLOW STATEMENT

The reclassified statement of cash flows shows the change in net financial indebtedness from the beginning to the end of the period.

Pursuant to IAS 7, the consolidated financial statements include a statement of cash flows that shows the change in cash and cash equivalents from the beginning to the end of the period.

(€ thousands) Q1 2023 Q1 2022
OPERATING ACTIVITIES:
Net profit (loss) attributable to the Group 29,299 30,613
Minority interests (40) 74
Amortization, depreciation and impairment:
- Intangible fixed assets 20,984 19,086
- Tangible fixed assets 12,954 12,445
- Right-of-use assets 28,137 26,118
Total amortization, depreciation and impairment 62,075 57,649
Provisions, other non-monetary items and gain/losses from disposals 16,405 2,871
Group's share of the result of associated companies (126) (59)
Financial income and charges 12,075 8,502
Current and deferred income taxes 12,359 13,027
Change in assets and liabilities:
- Utilization of provisions (1,417) (2,478)
- (Increase) decrease in inventories (10,689) (4,042)
- Decrease (increase) in trade receivables 896 (2,747)
- Increase (decrease) in trade payables (9,116) 13,048
- Changes in other receivables and other payables 19,175 (1,768)
Total change in assets and liabilities (1,150) 2,013
Net interest charges (10,846) (7,920)
Taxes paid (19,166) (6,693)
Cash flow provided by (used in) operating activities before repayment of lease liabilities 100,884 100,077
Repayment of lease liabilities (27,958) (25,587)
Cash flow generated from (absorbed) by operating activities 72,926 74,490
INVESTING ACTIVITIES:
Purchase of intangible fixed assets (10,807) (8,719)
Purchase of tangible fixed assets (17,710) (14,071)
Consideration from sale of tangible fixed assets and businesses 1,892 1,710
Cash flow generated from (absorbed) by investing activities (26,625) (21,080)
Cash flow generated from operating and investing activities (Free cash flow) 46,301 53,410
Business combinations (*) (38,799) (23,855)
(Purchase) sale of other investments and securities - 40
Net cash flow generated from acquisitions (38,799) (23,815)
Cash flow generated from (absorbed) by investing activities and acquisitions (65,424) (44,895)
(€ thousands) Q1 2023 Q1 2022
FINANCING ACTIVITIES:
Derivatives (1,483) -
Other non-current assets (313) 816
Treasury shares - (29,723)
Cash flow generated from (absorbed) by financing activities (1,796) (28,907)
Changes in net financial indebtedness net of lease liabilities 5,706 688
Net financial indebtedness at the beginning of the period (829,993) (871,186)
Effect of exchange rate fluctuations on net financial indebtedness (2,064) 1,927
Changes in net indebtedness 5,706 688
Net financial indebtedness at the end of the period net of lease liabilities (826,351) (868,571)

(*) The item refers to the net cash flows used in the acquisition of businesses and equity investments.

The change in net financial indebtedness of €5,706 thousand is attributable to:

  • (i) Investing activities:
  • capital expenditure on property, plant and equipment and intangible assets of €28,517 thousand relating primarily to the ongoing implementation and standardization of the Group cloud based ERP system, new investments made described in the "Net Invested Capital" section and network expansion;
  • acquisitions amounting to €38,799 thousand, including the impact of the acquired companies' debt and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years;
  • net proceeds from the disposal of assets of €1,892 thousand.
  • (ii) Operating activities:
  • interest payable on financial indebtedness and other net financial expenses of €10,846 thousand;
  • payment of taxes amounting to €19,166 thousand;
  • payment of principle on lease obligations of €27,958 thousand;
  • cash flow generated by current operations of €72,926 thousand.
  • (iii) Financing activities:
  • hedging instruments payment per €1.483 thousands;
  • negative changes in other non-current assets of other non-current assets per €313 thousands.
  • (iv) Net debt was also impacted by exchange losses of €2,064 thousand

Non-recurring transactions had a negative impact on cash flow of €1,342 thousand in the first three months of 2023 attributable for €1,187 thousand to the cost of GAES Integration, and €155 thousand to the integration of Bay Audio.

ACQUISITION OF COMPANIES AND BUSINESSES

During the first quarter of 2023, the Group continued with external growth operations and acquired 70 points of sale for a total investment of €38,799 thousand), including the debt consolidated and the best estimate of the earn-out linked to sales and profitability targets payable over the next few years.

More in detail, in the first quarter of 2023:

  • 27 points of sale were acquired in Canada;
  • 23 points of sale were acquired in China;
  • 8 points of sale were acquired in France;
  • 6 points of sale were acquired in Germany;
  • 3 points of sale were acquired in Spain;
  • 2 points of sale were acquired in Mexico;
  • 1 point of sale was acquired in the United States.

OUTLOOK

Contrary to the last three quarters of 2023, characterized by a slightly negative hearing care market trend, the Group estimates that in the first quarter of 2023 market demand was back to growth compared to the same period of 2022, though below historic levels. Therefore, even if the well-known uncertainties related to the macroeconomic environment persist, the Group now expects a positive market development throughout all of 2023.

In light of the above, assuming that there are no further slowdowns in global economic activity due to, among others, the well-known geopolitical and inflation related issues, in 2023 Amplifon expects to see strong growth in results, as follows:

  • consolidated revenues increasing significantly to €2.30-€2.35 billion (exchange rate for 2023: EUR/USD 1.07; EUR/AUD 1,57; EUR/ARS 227; EUR/EGP 32) (compared to €2.12 billion reported in 2022), supported by market share gains and bolt-on M&A, which will contribute around 2% to the revenue growth;
  • a recurring EBITDA in the range of €570-€585 million (compared to the €525 million posted in 2022), due to operating leverage and the new pricing actions implemented to offset the higher cost of labor, as well as support other strategic costs and investments.

In the medium-term the Group remains extremely positive on its prospects of sustainable growth in sales and profitability, thanks to the secular fundamentals of the hearing care market and its even stronger competitive positioning.

Milan, May 2nd 2023

CEO

Enrico Vita

Interim Financial Report as at 31 March 2023 > Interim Management Report

CONDENSED INTERIM CONSOLIDATED FINANCIAL

STATEMENTS AS AT 31 MARCH 2023

CONSOLIDATED STATEMENT OF FINANCIAL POSITION(*)

(€ thousands) 03/31/2023 12/31/2022 Change
ASSETS
Non-current assets
Goodwill Note 3 1,755,695 1,754,028 1,667
Intangible fixed assets with finite useful life Note 4 416,342 420,098 (3,756)
Property, plant, and equipment Note 5 197,866 193,415 4,451
Right-of-use assets Note 6 461,732 451,747 9,985
Equity-accounted investments 2,215 2,093 122
Hedging instruments 25,400 25,850 (450)
Deferred tax assets 86,540 81,780 4,760
Contract costs 11,870 11,131 739
Other assets 44,549 42,470 2,079
Total non-current assets 3,002,209 2,982,612 19,597
Current assets
Inventories 83,637 76,258 7,379
Trade receivables 190,274 192,067 (1,793)
Contract costs 4,831 5,262 (431)
Other receivables 89,728 72,610 17,118
Hedging instruments 276 17,016 (16,740)
Other financial assets 50,200 49,986 214
Cash and cash equivalents Note 8 179,654 (35,225)
Total current assets 563,375 592,853 (29,478)
Total assets 3,565,584 3,575,465 (9,881)

Interim Financial Report as at 31 March 2023 > Condensed Consolidated Financial Statements

(€ thousands) 12/31/2022 Change
LIABILITIES
Net Equity
Share capital Note 7 4,528 4,528 -
Share premium reserve 202,712 202,712 -
Treasury shares (49,262) (49,895) 633
Other reserves (9,930) 11,230 (21,160)
Retained earnings 868,794 691,409 177,385
Profit (loss) for the period 29,299 178,525 (149,226)
Group net equity 1,046,141 1,038,509 7,632
Minority interests 1,151 1,841 (690)
Total net equity 1,047,292 1,040,350 6,942
Non-current liabilities
Medium/long-term financial liabilities Note 9 738,735 798,940 (60,205)
Lease liabilities Note 11 373,474 368,890 4,584
Provisions for risks and charges Note 10 19,734 (210)
Liabilities for employees' benefits 8,841 8,940 (99)
Hedging instruments 454 - 454
Deferred tax liabilities 105,023 106,683
Payables for business acquisitions 5,490 5,705 (215)
Contract liabilities 156,831 153,613 3,218
Other long-term liabilities 16,479 16,123 356
Total non-current liabilities 1,425,061 1,478,838 (53,777)
Current liabilities
Trade payables 315,988 325,583 (9,595)
Payables for business acquisitions 16,417 24,601 (8,184)
Contract liabilities 114,492 114,857 (365)
Tax liabilities 89,494 74,785 14,709
Other payables 188,768 167,796 20,972
Hedging instruments 266 - 266
Provisions for risks and charges Note 10 2,395 1,663 732
Liabilities for employees' benefits 3,754 3,616 138
Short-term financial liabilities Note 9 256,117 243,661 12,456
Lease liabilities Note 11 99,716 5,824
Total current liabilities 1,093,231 1,056,277 36,954
TOTAL LIABILITIES 3,565,584 3,575,465 (9,881)

(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 17 for more details.

CONSOLIDATED INCOME STATEMENT(*)

(€ thousands) First three months 2023 First three months 2022
Recurring Non
recurring
Total Recurring Non
recurring
Total Change
Revenues from sales and services Note
12
540,251 - 540,251 495,808 - 495,808 44,443
Operating costs Note
13
(420,070) (7,892) (427,962) (384,518) (2,996) (387,514) (40,448)
Other income and costs 3,352 - 3,352 1,563 (51) 1,512 1,840
Gross operating profit (EBITDA) 123,533 (7,892) 115,641 112,853 (3,047) 109,806 5,835
Amortization, depreciation and impairment
Amortization of intangible fixed assets Note 4 (20,984) - (20,984) (19,110) - (19,110) (1,874)
Depreciation of property, plant, and
equipment
Note 5 (12,934) - (12,934) (12,371) - (12,371) (563)
Right-of-use depreciation Note 6 (28,137) - (28,137) (26,117) - (26,117) (2,020)
Impairment losses and reversals of non
current assets
(20) - (20) (51) - (51) 31
(62,075) - (62,075) (57,649) - (57,649) (4,426)
Operating result 61,458 (7,892) 53,566 55,204 (3,047) 52,157 1,409
Financial income, expenses and value
adjustments to financial assets
Group's share of the result of associated
companies valued at equity and gains/losses
on disposals of equity investments
126 - 126 49 - 49 77
Interest income and expenses (5,952) - (5,952) (4,661) - (4,661) (1,291)
Interest expenses on lease liabilities (3,263) - (3,263) (2,736) - (2,736) (527)
Other financial income and expenses (**) (1,202) - (1,202) (447) - (447) (755)
Exchange gains and losses, and inflation
accounting (**)
(1,978) - (1,978) 1,043 - 1,043 (3,021)
Gain (loss) on assets accounted at fair value
(**)
321 - 321 (1,692) - (1,692) 2,013
(11,948) - (11,948) (8,444) - (8,444) (3,504)
Profit (loss) before tax 49,510 (7,892) 41,618 46,760 (3,047) 43,713 (2,095)
Current and deferred income tax
Current tax (21,057) 2,306 (18,751) (17,363) 853 (16,510) (2,241)
Deferred tax 6,392 - 6,392 3,484 - 3,484 2,908
(14,665) 2,306 (12,359) (13,879) 853 (13,026) 667
Net profit (loss) 34,845 (5,586) 29,259 32,881 (2,194) 30,687 (1,428)
Net profit (loss) attributable to Minority
interests
(40) - (40) 74 - 74 (114)
Net profit (loss) attributable to the Group 34,885 (5,586) 29,299 32,807 (2,194) 30,613 (1,314)

(*) Transactions with related parties have not been reported separately because not material both at single entity and at consolidated level. Please refer to note 17 for more details.

(**) It is specified that, on the comparative period 2022, reclassifications between "Financial income, expenses and value adjustments to financial assets" have been made in order to better represent financial information.

Earnings per share (€ per share) Note 16 First three months
2023
First three months
2022
Earnings per share
-
Basic
-
Diluted
0.13048
0.12952
0.13638
0.13504

STATEMENT OF CONSOLIDATED COMPREHENSIVE INCOME

(€ thousands) First three months
2023
First three months
2022
Net income (loss) for the period 29,259 30,687
Other comprehensive income (loss) that will not be reclassified subsequently to profit or
loss:
Remeasurement of defined benefit plans (33) 751
Tax effect on components of other comprehensive income that will not be reclassified
subsequently to profit or loss
8 (149)
Total other comprehensive income (loss) that will not be reclassified subsequently to
profit or loss after the tax effect (A)
(25) 602
Other comprehensive income (loss) that will be reclassified subsequently to profit or loss:
Gains/(losses) on cash flow hedging instruments (1,178) 8,294
Gains/(losses) from Foreign Currency Basis Spread on hedging instruments 516 323
Gains/(losses) on exchange differences from translation of financial statements of foreign
entities
(31,747) 40,141
Tax effect on components of other comprehensive income that will be reclassified
subsequently to profit or loss
159 (2,068)
Total other comprehensive income (loss) that will be reclassified subsequently to profit or
loss after the tax effect (B)
(32,250) 46,690
Total other comprehensive income (loss) (A)+(B) (32,275) 47,292
Comprehensive income (loss) for the period (3,016) 77,979
Attributable to the Group (2,805) 77,892
Attributable to Minority interests (211) 87

STATEMENT OF CHANGES IN CONSOLIDATED EQUITY

(€ thousands) Share
capital
Share
premium
reserve
Legal
reserve
Other
reserves
Treasury
shares
reserve
Stock
option
and stock
grant
reserve
Balance at 01/01/2022 4,528 202,712 934 3,636 (28,841) 38,566
Allocation of profit (loss) for 2021
Share capital increase
Treasury shares (29,723)
Dividend distribution
Notional cost of stock grants 4,082
Other changes 625 (302)
- Stock Grant 625 (302)
- Inflation accounting
- Other changes
Total comprehensive income (loss) for the period - -
- Hedge accounting
- Actuarial gains (losses)
- Deferred taxes accounted for within Net Equity
- Translation differences
- Profit for the first three months of 2022
Balance at 31 March 2022 4,528 202,712 934 3,636 (57,939) 42,346
Stock
option
Share Treasury and stock
premium Legal Other shares grant
(€ thousands) Share capital reserve reserve reserves reserve reserve
Balance at 01/01/2023 4,528 202,712 934 3,636 (49,895) 35,182
Allocation of profit (loss) for 2022
Share capital increase
Treasury shares -
Dividend distribution
Notional cost of stock grants 11,063
Other changes 633 (119)
- Stock Grant 633 (119)
- Inflation accounting
- Other changes
Total comprehensive income (loss) for the
period
- -
- Hedge accounting
- Actuarial gains (losses)
- Deferred taxes accounted for within Net
Equity
- Translation differences
- Profit for the first three months of 2023
Balance at 31 March 2023 4,528 202,712 934 3,636 (49,262) 46,126
Cash flow
hedge
reserve
Foreign
Curr. Basis
Spread
Reserve
Actuarial gains
and losses
Retained
earnings
Translation
differences
Profit (loss)
for the period
Total
Shareholders'
equity
Minority
interests
Total net
equity
(1,033) (993) (7,010) 594,266 (39,372) 157,785 925,178 2,103 927,281
157,785 (157,785) - -
- -
(29,723) (29,723)
- - -
4,082 4,082
- - (410) (87) - (87)
(323) - -
- - -
(87) (87) - (87)
6,303 246 602 - 40,128 30,613 77,892 87 77,979
6,303 246 6,549 6,549
602 602 602
- - -
40,128 40,128 13 40,141
30,613 30,613 74 30,687
5,270 (747) (6,408) 751,641 756 30,613 977,342 2,190 979,532
Cash flow
hedge
reserve
Foreign Curr.
Basis Spread
Reserve
Actuarial
gains and
losses
Retained
earnings
Translation
differences
Profit (loss)
for the period
Total
Shareholders'
equity
Minority
interests
Total net
equity
19,913 (392) 2,782 691,409 (50,825) 178,525 1,038,509 1,841 1,040,350
178,525 (178,525) - -
- -
- -
- - -
11,063 11,063
- - (1,140) (629) (479) (1,105)
(289) 225 225
- - -
(851) (851) (479) (1,330)
(895) 392 (25) - (31,576) 29,299 (2,805) (211) (3,016)
(895) 392 (503) (503)
(25) (25) (25)
- - -
(31,576) (31,576) (171) (31,747)
29,299 29,299 (40) 29,259
19,018 - 2,757 868,794 (82,401) 29,299 1,046,141 1,151 1,047,292

STATEMENT OF CONSOLIDATED CASH FLOWS

(€ thousands) First three months
2023
First three months
2022
OPERATING ACTIVITIES
Net profit (loss) 29,259 30,687
Amortization, depreciation and impairment:
- intangible fixed assets 20,984 19,086
- property, plant, and equipment 12,954 12,446
- right-of-use assets 28,137 26,117
Provisions, other non-monetary items and gain/losses from disposals 16,405 2,870
Group's share of the result of associated companies (126) (59)
Financial income and expenses 12,075 8,502
Current and deferred taxes 12,359 13,027
Cash flow from operating activities before change in working capital 132,047 112,676
Utilization of provisions (1,417) (2,478)
(Increase) decrease in inventories (10,689) (4,042)
Decrease (increase) in trade receivables 896 (2,747)
Increase (decrease) in trade payables (9,116) 13,048
Changes in other receivables and other payables 19,175 (1,766)
Total change in assets and liabilities (1,151) 2,015
Interest received (paid) (13,272) (10,563)
Taxes paid (19,166) (6,694)
Cash flow generated from (absorbed by) operating activities (A) 98,458 97,434
INVESTING ACTIVITIES:
Purchase of intangible fixed assets (10,807) (8,719)
Purchase of tangible fixed assets (17,710) (14,071)
Consideration from sale of non-current assets 1,892 1,710
Cash flow generated from (absorbed by) operating investing activities (B) (26,625) (21,080)
Purchase of subsidiaries and business units net of cash and cash equivalents acquired or
dismissed
(38,799) (23,855)
Increase (decrease) in payables for business acquisitions (8,175) (9,014)
(Purchase) sale of other investments and securities - 40
Cash flow generated from (absorbed by) acquisition activities (C) (46,974) (32,829)
Cash flow generated from (absorbed by) investing activities (B+C) (73,599) (53,909)
FINANCING ACTIVITIES:
Increase (decrease) in financial payables (28,682) (17,609)
(Increase) decrease in financial receivables (316) (441)
Derivative instruments and other non-current assets (1,483) -
Commissions paid for medium/long-term financing (27,958) (25,586)
Principal portion of lease payments (313) 816
Treasury shares purchase - (29,723)
Cash flow generated from (absorbed by) financing activities (D) (58,752) (72,543)
Net increase in cash and cash equivalents (A+B+C+D) (33,893) (29,018)

Interim Financial Report as at 31 March 2023 > Condensed Consolidated Financial Statements

First three months First three months
(€ thousands) 2023 2022
Cash and cash equivalents at beginning of period 179,654 268,546
Effect of exchange rate fluctuations on cash & cash equivalents (1,332) 2,356
Flows of cash and cash equivalents (33,893) (29,018)
Cash and cash equivalents at end of period 144,429 241,884

Related-party transactions relate to lease of the main office and certain stores, to recharges of maintenance costs and general services of the above-mentioned buildings and to commercial transactions, personnel costs and loans. Such operations are detailed in Note 17.

SUPPLEMENTARY INFORMATION TO THE STATEMENT OF CONSOLIDATED CASH FLOWS

The fair values of the assets and liabilities acquired are summarized in the table below:

(€ thousands) First three months
2023
First three
months 2022
- Goodwill 29,406 17,944
- Customer lists 10,091 8,270
- Trademarks and non-competition agreements - 80
- Other intangible fixed assets 401 60
- Property, plant, and equipment 1,466 773
- Right-of-use assets 494 1,104
- Current assets 2,755 1,780
- Current liabilities (3,310) (1,952)
- Other non-current assets and liabilities (3,058) (3,204)
- Third parties equity 1,498 -
Total investments 39,743 24,855
Net financial debt acquired 349 283
Total business combinations 40,092 25,138
(Increase) decrease in payables through business acquisition 8,175 9,014
Purchase (sale) of other investments and securities - (40)
Cash flow absorbed by (generated from) acquisitions 48,267 34,112
(Cash and cash equivalents acquired) (1,293) (1,283)
Net cash flow absorbed by (generated from) acquisitions 46,974 32,829

NOTES

1. General Information

The Amplifon Group is global leader in the distribution of hearing solutions and the fitting of customized products.

The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.23% as at 31 March 2023), held for a 100% by Amplifin S.p.A., which is 99.4% owned by Susan Carol Holland and the remaining 0.6% in treasury shares.

The condensed interim consolidated financial report as at 31 March 2023 was prepared in accordance with International Accounting Standards, as well as the implementation regulations set out in Article 9 of Legislative Decree no. 38 of 28 February 2005. These standards include the IAS and IFRS issued by the International Accounting Standard Board, as well as the SIC and IFRIC interpretations issued by the International Financial Reporting Interpretations Committee, which were endorsed in accordance with the procedure set out in Article 6 of Regulation (EC) no. 1606 of 19 July 2002 by 31 March 2023. The International Accounting Standards endorsed after that date and before the preparation of this report were adopted in the preparation of the condensed interim consolidated financial report only if early adoption is allowed by the Endorsing Regulation and the standard itself and if the Group had elected to do so.

The condensed interim consolidated financial statements at 31 March 2023 do not include all the additional information required by the annual financial statements and must be read together with the annual consolidated financial statements of the Group at 31 December 2022.

The publication of the condensed interim consolidated financial statements of the Amplifon Group at 31 March 2023 was authorized by a resolution of the Board of Directors of 2 May 2023 which approved their publication.

According to the Consob Communication of 28 July 2006, it is specified that during the first three months of 2023 the Group did not carry out atypical and/or unusual transactions, as defined by the Communication itself.

2. Impact of the conflict in Ukraine, COVID-19 emergency, and climate change on the Group's performance and financial position

The Group has no business activities, direct or indirect, in either Ukraine, Russia or Belarus and limited activities in surrounding countries. The military conflict in Ukraine has not yet had any direct impact on the Group's performance or business. That said, in 2022 the Russian-Ukrainian conflict caused as strong increase in inflation worldwide causing the central banks to tighten monetary policies and raise interest rates which stabilized somewhat in the first quarter of 2023 but, however, continue to be very high. The economic recovery that characterized the first postpandemic phase slowed rapidly and the short/medium-term prospects remain uncertain and hard to assess with the possibility that an economic recession may materialize or persist. While the hearing aid market has always proven to be resilient even in times of economic crisis, as hearing solutions and services are non-discretional products which benefit people's physical, emotional and relational health significantly, and customers are assisted by public and private insurances, as well as consumer loans, the current inflationary environment and uncertainty about the future costs of basic necessities could cause a few potential customers to postpone the purchase of a hearing aid temporarily, particularly if needed in the medium-term. Although the Group monitors the changing macroeconomic environment and the relative impact on the business constantly, it cannot be excluded that the situation described above could cause the demand for the Group's services and products to slow even though, as mentioned before, Amplifon operates in a market segment which in the past, albeit in situations that are not directly comparable, has proven to be less sensitive than others to changes in the general economic cycle.

With respect to the Covid-19 heath crisis, the rollout of vaccination campaigns allowed for a gradual return to normalcy in a majority of the countries in which the Group operates already in the latter part of 2022. In the first three months of the 2023 the Group was not impacted by the health crisis, as shown by the excellent financial-economic results achieved by the Group.

As for climate change, the Group's business model is based on providing retail hearing solutions. The goals, therefore, connected to transitioning to alternative sources of energy and the actions needed to address climate change are pursued thanks to the steps taken by the Group to improve the energy efficiency of its business activities, as well as report on the greenhouse gas emissions generated along the value chain. Moreover, the Group's activities and business model do not entail significant exposure to the environmental risks connected specifically to climate change.

3. Acquisitions and goodwill

The Group continued its own balancing strategy between internal and external growth during the first three months of 2023 acquiring 70 points of sale. In detail, there were 30 points of sale purchased in Americas, 23 in Asia Pacific, and 17 in EMEA.

The total investment, including the indebtedness consolidated and the best estimate of the net change in the earn-out linked to sales and profitability targets payable over the next few years, amounted to €38,799 thousand.

The changes in goodwill and amounts recognized as a result of the acquisitions made in the period are reported in the table below and shown by groups of Cash Generating Units.

(€ thousands) Net carry at
12/31/2022
Business
combinations
completed in
the reporting
period
Disposals Impairment Other net changes Net carry at
03/31/2023
EMEA 921,163 7,374 - - (284) 928,253
AMERICAS 213,816 16,351 - - (6,094) 224,073
APAC 619,049 5,681 - - (21,361) 603,369
Total 1,754,028 29,406 - - (27,739) 1,755,695

"Business combinations completed in the reporting period" refers to the temporary allocation to goodwill of the portion of the purchase price paid, including deferments and contingent consideration (earn-outs), which is not directly attributable to the fair value of assets and liabilities, but is based on the positive contribution to cash flows that is expected to be made for an indefinite period of time.

"Other net changes" refers almost entirely to foreign exchange differences.

Identification of the Groups of Cash Generating Units

For the purposes of impairment testing the total goodwill stemming from the cost incurred for a business combination was allocated to groups of Cash Generating Units; these groups of Cash Generating Units were identified by region and benefit from synergies, as well as shared policies, and are autonomous in the management and use of resources.

The assets allocated to the groups of Cash Generating Units and the methods used to determine these groups are the same as those applied to the financial Statements as at 31 December 2022.

The groups of Cash Generating Units recognized are:

  • EMEA that includes Italy, France, the Netherlands, Germany, Belgium, Switzerland, Spain, Portugal, the UK, Hungary, Poland, Israel, and Egypt;
  • AMERICA which includes the individual businesses through which it operates in the US market (Franchising, Retail, and Managed Care) and the countries Canada, Argentina, Chile, Mexico, Panama, Ecuador, and Colombia;
  • ASIA PACIFIC that includes Australia, New Zealand, India, and China.

The recoverable value of goodwill is determined based on the value in use or, if the latter is less than book value, on fair value. As at 31 December 2022 the management's valuations were made taking into consideration the value in use. No loss in value was identified as a result of the impairment tests conducted at 31 December 2022.

The Group tests for impairment of goodwill once a year and in the event of any impairment indicators.

In the first quarter of 2023 the Group recorded growth against the first quarter of the prior year across all geographies and results were largely in line with the budget. The long-term risk free interest rate applied was slightly lower than the rate used for the FY 2022 impairment tests. The headroom at 31.12.2022 varied, depending on the geographic area, from 2% to 27%.

No indicators of impairment, therefore, emerged and for the purposes of measuring goodwill reference should be made to the impairment tests reported on in the Annual Report 2022.

A summary of the book value and the fair value of assets and liabilities, deriving from the temporary allocation of the purchase price made as a result of business combinations and the purchase of minority interests in subsidiaries, is provided in the following table.

(€ thousands) EMEA Americas APAC Total
Cost of acquisitions of the period 11,024 19,553 9,166 39,743
Assets and liabilities acquired – Book value
Current assets 339 1,123 - 1,462
Current liabilities (565) (1,140) (119) (1,824)
Net working capital (226) (17) (119) (362)
Other intangible, tangible and right-of-use assets 1,001 559 802 2,362
Other non-current assets and liabilities (321) (511) - (832)
Non-current assets and liabilities 680 48 802 1,530
Net invested capital 454 31 683 1,168
Third Parties Equity - 1,498 - 1,498
Net financial position 507 437 - 944
NET EQUITY ACQUIRED - BOOK VALUE 961 1,966 683 3,610
DIFFERENCE TO BE ALLOCATED 10,063 17,587 8,483 36,133
ALLOCATIONS
Customer lists 4,712 2,577 2,802 10,091
Contract liabilities - Short and long-term (1,287) (1,341) - (2,628)
Deferred tax assets 146 - - 146
Deferred tax liabilities (882) - - (882)
Total allocations 2,689 1,236 2,802 6,727
GOODWILL 7,374 16,351 5,681 29,406

4. Intangible fixed assets with useful life

The following table shows the changes in intangible assets.

(€ thousands) Historical cost
at 12/31/2022
Accumulated
amortization
and write
downs at
12/31/2022
Net book value
at 12/31/2022
Historical cost
at 03/31/2023
Accumulated
amortization
and write
downs at
03/31/2023
Net book value
at 03/31/2023
Software 235,964 (143,068) 92,896 240,534 (149,093) 91,441
Licenses 23,024 (18,450) 4,574 24,883 (19,326) 5,557
Non-competition agreements 14,328 (7,749) 6,579 14,869 (8,540) 6,329
Customer lists 464,959 (258,275) 206,684 471,263 (265,178) 206,085
Trademarks and concessions 96,559 (44,113) 52,446 95,111 (45,118) 49,993
Other 22,665 (11,292) 11,373 17,346 (7,348) 9,998
Fixed assets in progress and
advances
45,546 - 45,546 46,939 - 46,939
Total 903,045 (482,947) 420,098 910,945 (494,603) 416,342
(€ thousands) Net book
value at
12/31/2022
Investments Disposals Amortization Business
combinations
Impairment Other
net
changes
Net book
value at
03/31/2023
Software 92,896 2,044 7 (7,829) - - 4,323 91,441
Licenses 4,574 40 - (837) - - 1,780 5,557
Non-competition
agreements
6,579 324 - (903) - - 329 6,329
Customer lists 206,684 15 93 (9,065) 10,091 - (1,733) 206,085
Trademarks and
concessions
52,446 - - (1,953) 4 - (504) 49,993
Other 11,373 236 (953) (397) - - (261) 9,998
Fixed assets in
progress and
advances
45,546 8,148 (50) - 397 - (7,102) 46,939
Total 420,098 10,807 (903) (20,984) 10,492 - (3,168) 416,342

The investments in intangible fixed assets recorded in the reporting period (€10,807 thousand) are attributable to the ongoing implementation and standardization of the Group cloud-based ERP system for back-office functions (HR, Procurement, Administration and Finance), the new front office solutions and the AI technologies used to provide customers with a highly personalized experience.

The change in "Business combinations" comprises:

  • For €4,716 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
  • For €2,974 thousand, the temporary allocation of the price paid for acquisitions made in Americas;
  • For €2,802 thousand, the temporary allocation of the price paid for acquisitions made in APAC.

The item "Other net changes" is explained almost entirely by foreign exchange differences and the reclassification of work in progress completed in the period.

5. Property, plant, and equipment

The following table shows the changes in property, plant, and equipment.

(€ thousands) Historical cost
at 12/31/2022
Accumulated
amortization
and write
downs at
12/31/2022
Net book value
at 12/31/2022
Historical cost
at 03/31/2023
Accumulated
amortization
and write
downs at
03/31/2023
Net book value
at 03/31/2023
Land 154 - 154 142 - 142
Buildings, constructions and
leasehold improvements
298,991 (199,083) 99,908 302,393 (202,696) 99,697
Plant and machines 52,414 (42,077) 10,337 53,017 (42,782) 10,235
Industrial and commercial
equipment
76,808 (58,052) 18,756 78,991 (59,834) 19,157
Motor vehicles 1,047 (776) 271 1,154 (802) 352
Computers and office
machinery
80,108 (62,712) 17,396 80,435 (63,295) 17,140
Furniture and fittings 124,155 (91,452) 32,703 124,883 (92,618) 32,265
Other tangible fixed assets 5,673 (3,031) 2,642 6,983 (4,237) 2,746
Fixed assets in progress and
advances
11,248 - 11,248 16,132 - 16,132
Total 650,598 (457,183) 193,415 664,130 (466,264) 197,866
(€ thousands) Net book
value at
12/31/2022
Investments Disposals Amortization Business
combinations Impairment
Other
net
changes
Net book
value at
03/31/2023
Land 154 - - - - - (12) 142
Buildings, constructions and
leasehold improvements
99,908 4,630 (24) (6,018) 10 (21) 1,212 99,697
Plant and machines 10,337 532 - (746) 179 (2) (65) 10,235
Industrial and commercial
equipment
18,756 1,916 (51) (1,753) 46 - 243 19,157
Motor vehicles 271 85 (3) (22) 20 - 1 352
Computers and office
machinery
17,396 731 54 (2,007) 719 - 247 17,140
Furniture and fittings 32,703 1,302 27 (2,225) 49 - 409 32,265
Other tangible fixed assets 2,642 82 - (163) - - 185 2,746
Fixed assets in progress and
advances
11,248 8,432 (36) - 443 3 (3,958) 16,132
Total 193,415 17,710 (33) (12,934) 1,466 (20) (1,738) 197,866

The investments made in the reporting period refer primarily to the network expansion with the opening of new stores and renewal of existing ones, as well as to the purchase of hardware needed for the implementation of Group Information Technology projects.

The change in "business combinations" comprises:

  • for €651 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
  • for €132 thousand, the temporary allocation of the price paid for acquisitions made in Americas;

  • for €683 thousand, the temporary allocation of the price paid for acquisitions made in APAC.

"Other net changes" is explained primarily by foreign exchange differences recorded in the reporting period and the reclassification of work in progress completed in the period.

6. Right-of-use assets

(€ thousands) Historical cost
at 12/31/2022
Accumulated
amortization
and write
downs at
12/31/2022
Net book value
at 12/31/2022
Historical cost
at 03/31/2023
Accumulated
amortization
and write
downs at
03/31/2023
Net book value
at 03/31/2023
Stores and offices 777,889 (336,445) 441,444 791,263 (341,286) 449,977
Motor vehicles 24,819 (15,365) 9,454 25,727 (15,772) 9,955
Electronic machinery 1,657 (808) 849 2,780 (980) 1,800
Total 804,365 (352,618) 451,747 819,770 (358,038) 461,732

Right-of-use assets are reported here below:

Net book Other Net book
value at Business net value at
(€ thousands) 12/31/2022 Increase Decrease Depreciation combinations Impairment changes 03/31/2023
Stores and offices 441,444 37,161 (5,465) (26,559) 494 - 2,902 449,977
Motor vehicles 9,454 1,958 (294) (1,388) - - 225 9,955
Electronic machinery 849 1,185 - (190) - - (44) 1,800
Total 451,747 40,304 (5,759) (28,137) 494 - 3,083 461,732

The increase in right of use assets acquired in the year is explained by the renewal of existing leases and the network expansion.

The change in "business combinations" comprises:

  • for €345 thousand, the temporary allocation of the price paid for acquisitions made in EMEA;
  • for €30 thousand, the temporary allocation of the price paid for acquisitions made in Americas;
  • for €119 thousand, the temporary allocation of the price paid for acquisitions made in APAC.

"Other changes" refers mainly to foreign exchange differences recorded in the reporting period.

7. Share capital

On 31 March 2023 the share capital comprised 226,388,620 ordinary shares with a par value of €0.02 fully paid in and subscribed, unchanged concerning 31 December 2022.

A total of 23,225 of the performance stock grant rights were exercised in the period, as a result of which the Group transferred the same number of treasury shares to the beneficiaries.

A total of 1,808,135 treasury shares, or 0.799% of the parent's share capital, were held at 31 March 2023.

Information relating to the treasury shares held is shown below:

Average purchase price (Euro) Total amount
No. of shares FV of transferred rights (Euro) (€ thousands)
Held at 12/31/2022 1,831,360 27.245 49,895
Purchases - - -
Transfers due to exercise of performance stock grants (23,225) 27.245 (633)
Held at 03/31/2023 1,808,135 27.245 49,262

8. Net financial position

The Group's net financial position, including lease liabilities, prepared in accordance with the ESMA guideline 32-382-1138 of 4 March 2021 and CONSOB's Warning Notice n. 5/21 of 29 April 2021, is shown below.

(€ thousands) 03/31/2023 12/31/2022 Change
Cash (A) 144,429 179,654 (35,225)
Cash equivalents (B) - - -
Short term investments (C) 50,182 49,968 214
Total Cash, Cash Equivalents and Short-Term Investments (A+B+C)
(D)
194,611 229,622 (35,011)
Current financial payables (including bonds, but excluding current
portion of medium/long-term debt) (E)
253,143 221,095 32,048
- Bank borrowings 172,895 116,659 56,236
- Private Placement 2013-2025 - 103,131 (103,131)
- Other financial payables and bank overdrafts 80,258 19,697 60,561
- Hedging derivatives (10) (18,392) 18,382
Current portion of medium/long-term financial debt (F) 126,211 130,329 (4,118)
- Financial accruals and deferred income 4,254 6,012 (1,758)
- Payables for business acquisitions 16,417 24,601 (8,184)
- Lease Liability – current portion 105,540 99,716 5,824
Current Financial Indebtedness (E+F) (G) 379,353 351,424 27,929
Current Financial Indebtedness (G-D) (H) 184,742 121,802 62,940
Non current financial payables (I) 770,623 826,797 (56,174)
- Bank borrowings – Non current portion 391,659 452,202 (60,543)
- Payables for business acquisitions – Non current portion 5,490 5,705 (215)
- Lease Liability – Non current portion 373,474 368,890 4,584
Bonds (J) 350,000 350,000 -
- Eurobond 2020-2027 350,000 350,000 -
Trade and other non current payables (K) - - -
- Hedging derivatives – non current portion - - -
Non Current Financial Indebtedness (I+J+K) (L) 1,120,623 1,176,797 (56,174)
Total Financial Indebtedness (H+L) (M) 1,305,365 1,298,599 6,766

Excluding lease liabilities (€479,014 thousand at 31 March 2023), net financial debt amounted to €826,351 thousand at 31 March 2023, broken down as follows:

(€ thousands) 03/31/2023 12/31/2022 Change
Cash and Cash Equivalents 144,429 179,654 (35,225)
Short Term Investments 50,182 49,968 214
Cash, Cash Equivalents and Short Term Investments 194,611 229,622 (35,011)
Current Financial Indebtedness (excluding lease
liabilities)
273,813 251,708 22,105
Current Financial Indebtedness (excluding lease
liabilities)
79,202 22,086 57,116
Non current Financial Indebtedness (excluding lease
liabilities)
747,149 807,907 (60,758)
Total Financial Indebtedness (excluding lease liabilities) 826,351 829,993 (3,642)

At the end of January 2023 the entire Private Placement 2013-2025 was repaid in advance (€85,371 thousand at the hedging rate).

Long-term net financial debt, excluding lease liabilities, amounted to €747,149 thousand at 31 March 2023 which is €60,758 thousand lower than the €807,907 thousand recorded at 31 December 2022. The change is attributable mainly to the reclassification as short-term debt of the portions of long-term debt maturing in the next 12 months.

The short-term portion of the net financial debt, excluding lease liabilities, increased by €57,116 thousand, going from €22,086 thousand at 31 December 2022 to €79,202 thousand at 31 March 2023. The short-term portion of long-term debt and the other short-term components of financial debt exceed available liquidity, other cash equivalents and other short-term liquid assets. The company, however, has unutilized, irrevocable lines of credit of €255,000 thousand which, in addition to the €148 million in available uncommitted credit lines and the cash generation expected for the remainder of 2023, ensure enough liquidity to satisfy current obligations and support business needs.

More specifically, the short-term portion of the net financial position includes the short-term portion of long-term bank loans (€172,895 thousand), other bank debt of €79,959 thousand including hot money and utilization of short-term credit lines, interest payable on the Eurobond (€514 thousand), as well as on other bank borrowings (€3,740 thousand), and lastly, the best estimate of the deferred payments for acquisitions (€16,417 thousand), net of the €194,611 thousand in liquidity. Liquidity includes €144,429 thousand in available cash and €50,182 thousand in other financial assets that are easily liquidated. These financial assets refer to investments made in money market funds managed by top-tier financial institutions.

Bank loans, and the Eurobond 2020-2027 are included in the statement of financial position as follows:

a. under the item "medium/long-term financial liabilities".

(€ thousands) Balance at 03/31/2023
Eurobond 2020-2027 350,000
Other medium/long-term debt 391,659
Fees on Eurobond 2020-2027 and bank loans (2,924)
Medium/long-term financial liabilities 738,735

b. under the item "financial payables (current)".

(€ thousands) Balance at 03/31/2023
Bank overdraft and other short-term debt (including current portion of other long-term debt) 253,153
Other financial payables 4,254
Fees on bank loans (1,290)
Short-term financial liabilities 256,117

All the other items in the net financial position table can be easily referred to in the financial consolidated statements.

9. Financial liabilities

The financial liabilities breakdown is as follows:

(€ thousands) Balance at
03/31/2023
Balance at
12/31/2022
Change
Eurobond 2020-2027 350,000 350,000 -
Other medium long-term bank loans 391,659 452,202 (60,543)
Fees on Eurobond 2020-2027, bank loans, and private placement 2013-2025 (2,924) (3,262) 338
Total medium/long-term financial liabilities 738,735 798,940 (60,205)
Short term debt 256,117 243,661 12,456
- of which current portion of short-term bank loans 172,895 116,659 56,236
- of which current portion of private placement 2013-2025 - 103,131 (103,131)
- of which debts for account overdrafts and other short-term liabilities 79,959 18,212 61,747
- of which fees for bank loans and private placement 2013-2025 (1,290) (1,245) (45)
Total short-term financial liabilities 256,117 243,661 12,456
Total financial liabilities 994,852 1,042,601 (47,749)

The main financial liabilities are detailed below.

- Eurobond 2020-2027

This is a €350,000 thousand 7-year nonconvertible bond with a fixed annual coupon of 1.125% that is listed on the Luxembourg Stock Exchange's unregulated market.

Issue Date Debtor Maturity Nominal value
(€/000)
Fair Value
(€/000)
Nominal
interest
rate (*)
Euro
interest
rate after
hedging
02/13/2020 Amplifon S.p.A. 02/13/2027 350,000 306,774 1.125% N/A
Total in Euro 350,000 306,774

(*) The nominal interest rate is equal to the mid swap plus a spread.

  • Bank loans

These are the main bilateral and pooled loans which are detailed below:

Issue Date Debtor Type Maturity Nominal
value
(€/000)
Outstanding
debt
(€/000)
Fair Value
(€/000)
Nominal
interest
rate (*)
Hedged
nominal
amount
(**)
Interest
rate after
hedging
(**)
04/30/2020 Amplifon S.p.A. Amortizing 04/30/2023 30,000 3,772 3,798 3.592%
04/07/2020 Amplifon S.p.A. Bullet 03/22/2024 60,000 60,000 61,493 4.032%
04/06/2020 Amplifon S.p.A. Amortizing 04/06/2025 50,000 35,714 36,424 3.420% 35,714 1.012%
04/07/2020 Amplifon S.p.A. Amortizing 04/07/2025 150,000 120,000 123,501 3.088% 80,000 1.17%
04/28/2020 Amplifon S.p.A. Amortizing 04/28/2025 50,000 50,000 51,056 3.168% 1.530%
04/29/2020 Amplifon S.p.A. Amortizing 04/29/2025 78,000 48,750 50,330 3.768% 34,125 1.540%
04/23/2020 Amplifon S.p.A. Amortizing 06/30/2025 35,000 31,500 32,244 3.826% 31,500 0.990%
08/03/2020 Amplifon S.p.A. Amortizing 06/30/2025 10,000 4,565 4,623 3.252%
12/23/2021 Amplifon S.p.A. Amortizing 12/23/2026 210,000 210,000 211,295 3.602% 210,000 1.163%
Total 673,000 564,301 574,764 391,339

(*) The nominal interest rate comprises the benchmark rate (Euribor) plus the applicable spread.

(**) An Interest Rate Swap was used to hedge these loans against interest rate risk at the IRS rate plus a spread.

Group's loans, bonds, and revolving credit lines are subject to the following financial covenants:

  • the net financial indebtedness, excluding lease liabilities, to Group net equity (Net Worth Ratio) must not exceed 1.65;
  • the Leverage Ratio, calculated as the ratio of net financial debt, excluding lease liabilities, to EBITDA recorded in the last four quarters (determined excluding the fair value of the stock-based payments, based solely on recurring business, and restated if the Group's structure should change significantly), must not exceed 2.85;
  • the Interest Cover, calculated as the ratio of EBITDA (restated like the EBITDA used to calculate the leverage ratio) recorded in the last four quarters and the net interest owed in the same four quarters, must not exceed 4.9.

Typically, in the event of relevant acquisitions, the first two ratios may be increased to 2.20 and 3.26, respectively, for a period of not more than 12 months, twice over the life of the respective loans.

The trigger events for these covenants and the "spikes" relative to significant acquisitions (i.e. increase in benchmark index for maximum 12 months and twice along the duration of the financial liability) are summarized below:

Primary Credit Facility Agreement Leverage Ratio Net Worth Ratio Interest Cover Spike
- Medium/long-term bilateral loans
with top-tier banking institutions of
€238 million.
≤ 2.85 ≤ 1.65 -
3.26
(Leverage
Ratio)
- Irrevocable credit lines with top-tier
banking institutions of €125 million.
≤ 2.20 (Net Worth
Ratio)
- €36 million bank loan expiring in 2025
- Revolving irrevocable credit line of
€15 million
≤ 2.85 - > 4.90
3.26
(Leverage
Ratio)
-Medium/long-term bilateral loans
with top-tier banking institutions of

3.26
(Leverage
Ratio)
€80 million;
- Irrevocable credit lines with top-tier
banking institutions of €115 million;
≤ 2.85 ≤ 1.65 > 4.90 ≤ 2.20 (Net Worth
Ratio)

The €210 million "sustainability-linked" line negotiated at year-end 2021 used to refinance the syndicated loan for the GAES acquisition is not subject to financial covenants. However, the financial covenants on the other credit facilities will also be extended to the lenders of the "sustainability-linked" facility as a result of a most favored clause.

The three financial covenants and the relative spikes, shown in the table above, are, therefore, applied to this credit line as long as they are also applied to the other facilities.

As at 31 March 2023 these ratios were as follows:

Value as at
03/31/2023
Net financial indebtedness excluding lease liabilities/Group net equity (Net Worth Ratio) 0.79
Net financial position excluding lease liabilities/EBITDA for the last four quarters (Leverage Ratio) 1.48
EBITDA for the last 4 quarters/Net financial expenses (Interest Cover) 25.74

The above-mentioned ratios were determined based on an EBITDA which was restated and normalized, in order to reflect the main changes.

(€ thousands) Value as at 03/31/2023
Group EBITDA first three months 2023 115,641
EBITDA April-December 2022 408,903
Fair value of stock grant assignment 12,988
EBITDA normalized (from acquisitions and disposals) 9,026
Acquisitions and non-recurring costs 11,131
EBITDA for the covenant calculation 557,689

The same agreements are also subject to other covenants applied in current international practice which limit the ability to issue guarantees and complete sales and lease backs, as well as extraordinary transactions involving the sale of assets.

10. Provision for risk and charges

Provisions for risks and charges amounted to €22,129 thousand, largely in line with the €21,607 thousand recorded at 31 December 2022.

The provisions for risks at 31 March 2023 are detailed below:

(€ thousands) 03/31/2023 12/31/2022 Change
Product warranty provision 1,161 1,261 (100)
Provision on contract risks 4,085 4,515 (430)
Agents' leaving indemnities 12,077 11,735 342
Other reserves for risks and charges 2,411 2,433 (22)
Total Long-term provision for risk and charges 19,734 19,944 (210)
Product warranty provision 479 323 156
Other reserves for risks and charges 1,916 1,340 576
Total Short-term provision for risk and charges 2,395 1,663 732
Total provision for risk and charges 22,129 21,607 522

11. Lease liabilities

The lease liabilities stem from long-term leases and rental agreements. These liabilities are equal to the present value of future installments payable over the lease term.

The finance lease liabilities are shown in the statement of financial position as follows:

(€ thousands) 03/31/2023 12/31/2022 Change
Short term lease liabilities 105,540 99,716 5,824
Long term lease liabilities 373,474 368,890 4,584
Total lease liabilities 479,014 468,606 10,408

The impact of the lease liabilities recognized in the reporting period on the income statement is shown below:

First three months
(€ thousands) 2023
Interest charges on leased assets (3,263)
Right-of-use depreciation (28,137)
Costs for short-term leases and leases for low value assets (3,550)

12. Revenues from sales and services

(€ thousands) First three months 2023 First three months 2022 Change
Revenues from sale of products 469,108 437,789 31,319
Revenues from services 71,143 58,019 13,124
Total revenues from sales and services 540,251 495,808 44,443
Goods and services provided at a point in time 469,108 437,789 31,319
Goods and services provided over time 71,143 58,019 13,124
Total revenues from sales and services 540,251 495,808 44,443

Consolidated revenues from sales and services amounted to €540,521 thousand in the first three months of 2023, an increase of €44,443 thousand (+9.0%) compared to the same period of the prior year.

The increase compared to the first quarter of 2022 is attributable for €36,934 thousand to organic growth (+7.4%), acquisitions for €9,255 thousand (+1.9%) and negative exchange differences for €1,746 thousand (-0.3%).

13. Operating costs, depreciation and impairment, financial income-expenses and taxes

Operating costs amounted to €427,962 thousand in the first quarter of 2023 (€387,514 thousand in the first quarter of 2022), an increase of €40,448 thousand (+10.4%).

"Amortization, depreciation and impairment" amounted to €62,075 thousand at 31 March 2023, higher than the €57,649 thousand recorded in the first three months of 2022.

"Financial income, expenses and value adjustments to financial assets" came to €11,948 thousand in the first quarter of 2023 (€8,444 thousand in the first three months of 2022). The change in the reporting period is attributable mainly to an increase in financial expenses stemming from higher interest rates on the utilization of short-term credit lines (most of the long-term debt is fixed rate) and the negative exchange differences recorded primarily in North and South America.

Current and deferred tax amounted to €12,359 thousand in the first quarter of 2023, €667 thousand lower than in the first three months of 2022 (€13,026 thousand). The tax rate was 29.7% in the reporting period versus 29.8% at 31 March 2022.

14. Performance Stock Grant

On 5 January 2023 the majority shareholder Ampliter S.r.l. ("Ampliter") issued a plan which provides for the one-off assignment, free of charge, of up to a maximum of 500,000 of the Amplifon shares owned by Ampliter, to the Chief Executive Officer Enrico Vita, during the current mandate 2022-2024.

The shares will be transferred, free of charge, in five tranches, comprising a first tranche of 260,000 shares and subsequent ones of 60,000 shares each.

As a result of this assignment, which was made completely autonomously by Ampliter and does not envisage any cash-out by Amplifon, based on IFRS 2 "Share Based Payments" an estimated one-off notional cost of €13.7 million will be recognized in the income statement, of which €12.4 million in 2023 and €1.3 million in 2024.

The fair value per share recognized in accordance with IFRS 13 equaled the mark to market (Level 1) of the rights at the assignment date or €27.43.

The notional cost for the first quarter was €7,294 thousand which was recognized as a nonrecurring expense at 31 March 2023.

15. Non-recurring significant events

(€ thousands) First three months
2023
First three months
2022
Costs related to Bay Audio integration - (1,000)
Costs related to second phase of the GAES integration (598) (1,047)
Operating costs Costs related to the charitable donation to the UNHCR for the
Ukraine emergency.
- (1,000)
Notional cost of the Amplifon shares assigned by the shareholder
Ampliter to the CEO
(7,294) -
Profit (loss) from operating activities (7,892) (3,047)
Profit (loss) before tax (7,892) (3,047)
Impact of the above items on the tax burden for the period 2,306 853
Total net profit (loss) (5,586) (2,194)

The first three months of 2023 were impacted by the following non-recurring items:

16. Earnings (loss) per share

Basic Earnings (loss) per share

Basic earnings (loss) per share is obtained by dividing the net profit for the year attributable to the ordinary shareholders of the parent company by the weighted average number of shares outstanding in the period, considering purchases and disposals of own shares as cancellations and issues of shares.

Earnings per share are determined as follows:

Earnings per share First three months
2023
First three months
2022
Net profit (loss) attributable to ordinary shareholders (€ thousand) 29,299 30,613
Average number of shares outstanding in the period 224,551,388 224,476,338
Average earnings per share (€ per share) 0.13048 0.13638

Diluted earnings (loss) per share

Diluted earnings (loss) per share is obtained by dividing the net profit for the period attributable to the ordinary shareholders of the parent by the weighted average number of shares outstanding during the year adjusted by the diluting effects of potential shares. In the calculation of shares outstanding, purchases and sales of treasury shares are considered as cancellation or issue of shares.

The potential ordinary share categories refer to the possible conversion of Group employees' stock options and stock grants' attribution. The computation of the average number of outstanding potential shares is based on the average fair value of shares for the period; stock options and stock grants are excluded from the calculation since they have anti-diluting effects.

Weighted average diluted number of shares outstanding First three months 2023 First three months 2022
Average number of shares outstanding in the period 224,551,388 224,476,338
Weighted average of potential and diluting ordinary shares 1,673,108 2,218,858
Weighted average of shares potentially subject to options in the period 226,224,496 226,695,196

The diluted earnings per share were determined as follows:

Diluted earnings per share First three months
2023
First three months
2022
Net profit attributable to ordinary shareholders (€ thousand) 29,299 30,613
Average number of shares outstanding in the period 226,224,496 226,695,196
Average diluted earnings per share (€) 0.12952 0.13504

17. Transactions with parents and other related parties

The parent company, Amplifon S.p.A. is based in Via Ripamonti 133, Milan, Italy. The Group is controlled directly by Ampliter S.r.l. (42.23% of share capital and 59.27% of voting rights), held for a 100.0% by Amplifin S.p.A., which is 99.4% owned by Susan Carol Holland and the remaining 0.6% in treasury shares.

The transactions with related parties, including intercompany transactions, do not qualify as atypical or unusual, and fall within the Group's normal course of business and are conducted at arm's-length as dictated by the nature of the goods and services provided.

03/31/2023 First three months 2023
(€ thousands) Trade
receivables
Trade payables Other
receivables
Revenues for sales
and services
Operating
(costs)/revenues
Interest
income and
expense
Amplifin S.p.A. 27 - 624 - (48) 2
Total – Parent 27 - 624 - (48) 2
Comfoor BV (The Netherlands) 47 2,754 - 20 (271) -
Ruti Levinson Institute Ltd (Israel) 93 - - - - -
Afik - Test Diagnosis & Hearing
Aids Ltd (Israel)
165 - - - - -
Total – Other related parties 305 2,754 - 20 (271) -
Total related parties 332 2,754 624 20 (319) 2
Total as per financial statements 190,274 315,988 89,728 540,251 (427,962) (5,952)
% of financial statements total 0.17% 0.87% 0.70% 0.00% 0.07% -0.03%

The following table details transactions with related parties:

The trade and other receivables refer primarily to:

  • the recovery of maintenance costs and building fees from Amplifin S.p.A.;
  • the receivables due by Amplifin S.p.A. for the renovation of the headquarters based on modern and efficient standards for the use of workspaces;
  • the trade receivables due by associates (mainly in Israel) who act as resellers and to which the Group supplies hearing aids.

The trade payables and operating costs refer primarily to commercial transactions with Comfoor BV, a joint venture from which hearing protection devices are purchased and then distributed in Group stores.

The lease for the Milan headquarters (leased to Amplifon by the parent company Amplifin) is recognized under right-of-use depreciation for €455 thousand, interest on leases for €70 thousand, lease liabilities of €14,061 thousand, and right-of-use asset of €12,273 thousand.

The assignment of Amplifon shares by Ampliter S.r.l. to the CEO Enrico Vita described in note 14, is a transaction between related parties and not a transaction with related parties.

18. Contingent liabilities

Currently the Group is not exposed to any particular risks, uncertainties or legal disputes in excess of the provisions already made in the financial statements, shown in Note 10. The usual tax audits are currently underway and no findings of note have been reported so far and the Group is, at any rate, confident in the adequacy of the measures implemented.

19. Financial risk management

As this condensed consolidated interim financial report does not include all the additional information that is mandatorily included in the Annual Report relating to the management of financial risk, for a detailed analysis of financial risk management reference should be made to the Group's 2022 Annual Report.

Interim Financial Report as at 31 March 2023 > Condensed Consolidated Financial Statements

20. Translation of foreign companies' financial statements

The exchange rates used to translate non-Euro zone companies' financial statements are as follows:

31 March 2023 2022 31 March 2022
Average exchange rate As at
31 March
As at
31 December
Average exchange
rate
As at
31 March
Panamanian balboa 1.0730 1.0875 1.0660 1.1101 1.1217
Australian dollar 1.5701 1.6268 1.5693 1.4829 1.5491
Canadian dollar 1.4513 1.4737 1.4440 1.3896 1.4206
New Zealand dollar 1.7040 1.7392 1.6798 1.6014 1.6584
Singapore dollar 1.4302 1.4464 1.4300 1.5028 1.5169
US dollar 1.0730 1.0875 1.0666 1.1101 1.1217
Hungarian florin 388.71 379.50 400.87 369.77 364.60
Swiss franc 0.9925 0.9968 0.9847 1.0267 1.0364
Egyptian lira 32.1589 33.5530 26.3990 20.280 18.037
New Israeli shekel 3.7959 3.9284 3.7554 3.5243 3.5869
Argentine peso (*) 226.8909 226.8909 188.5033 123.1020 123.1020
Chilean peso 870.78 858.85 913.82 875.81 907.57
Colombian peso 5,106.29 5,048.97 5,172.47 4,167.38 4,389.67
Mexican peso 20.0431 19.6392 20.8560 22.0903 22.9919
Brazilian real 5.5750 5.5158 5.6386 5.3009 5.8696
Chinese renminbi 7.3419 7.4763 7.3582 7.0403 7.1212
Indian rupee 88.2438 89.3995 88.1710 84.1340 84.3944
British pound 0.8831 0.8792 0.8869 0.8460 0.8364
Polish zloty 4.7081 4.6700 4.6808 4.6531 4.6230

(*) Argentina is a highly inflationary country. As requested by IAS 29, profit and loss items have been converted at the closing exchange rate.

The average Argentine peso exchange rate as at 31 March 2023 is 206.2678 and as at 31 March 2022 is 119.4929.

21. Segment reporting

In accordance with IFRS 8 "Operating Segments", the schedules related to each operating segment are shown below.

The Amplifon Group's business (distribution and customization of hearing solutions) is organized into three specific geographical areas which comprise the Group's operating segments: Europe, Middle-East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Spain, Portugal, Switzerland, Belgium, Hungary, Egypt, Poland, and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama, and Mexico) and Asia-Pacific (Australia, New Zealand, India, and China).

The Group also operates via centralized Corporate functions (Corporate bodies, general management, business development, procurement, treasury, legal affairs, human resources, IT systems, global marketing and internal audit) which do not qualify as operating segments under IFRS 8.

These areas of responsibility, which coincide with the geographical areas (the Corporate functions are recognized under EMEA), represent the organizational structure used by management to run the Group's operations. The reports periodically analyzed by the Chief Executive Officer and Top Management are divided up accordingly, by geographical area.

Performances are monitored and measured for each operating segment/geographical area, through operating profit including amortization and depreciation (EBIT), along with the portion of the results of equity investments in associated companies valued by using the equity method. Financial expenses are not monitored insofar as they are based on corporate decisions regarding the financing of each region (own funds versus borrowings) and, consequently, neither are taxes. Items in the statement of financial position are analyzed by the geographical area without being separated from the Corporate functions which remain part of EMEA. All the information relating to the income statement and the statement of financial position is determined using the same criteria and accounting standards used to prepare the consolidated financial statements.

Statement of Financial Position as at March 31st , 2023 (*)

(€ thousands) EMEA AMERICAS APAC ELIM. CONSOLIDATED
ASSETS
Non-current assets
Goodwill 928,253 224,073 603,369 - 1,755,695
Intangible fixed assets with finite useful life 296,921 54,571 64,850 - 416,342
Property, plant, and equipment 142,337 22,072 33,457 - 197,866
Right-of-use assets 368,629 38,521 54,582 - 461,732
Equity-accounted investments 2,215 - - - 2,215
Hedging instruments 25,400 - - - 25,400
Deferred tax assets 65,681 10,115 10,744 - 86,540
Deferred contract costs 10,582 1,218 70 - 11,870
Other assets 30,679 12,072 1,798 - 44,549
Total non-current assets 3,002,209
Current assets
Inventories 67,895 6,018 9,724 - 83,637
Receivables 264,043 45,675 31,608 (61,324) 280,002
Deferred contract costs 3,959 778 94 - 4,831
Hedging instruments 276 - - - 276
Other financial assets 50,200
Cash and cash equivalents 144,429
Total current assets 563,375
TOTAL ASSETS 3,565,584
LIABILITIES
Net Equity 1,047,292
Non-current liabilities
Medium/long-term financial liabilities 738,735
Lease liabilities 303,413 32,492 37,569 - 373,474
Provisions for risks and charges 17,541 771 1,422 - 19,734
Liabilities for employees' benefits 7,927 214 700 - 8,841
Hedging instruments 454 - - - 454
Deferred tax liabilities 61,782 25,519 17,722 - 105,023
Payables for business acquisitions 3,292 2,198 - - 5,490
Contract liabilities 139,605 14,935 2,291 - 156,831
Other long-term liabilities 15,181 1,298 - - 16,479
Total non-current liabilities 1,425,061
Current assets
Trade payables 278,258 58,609 40,249 (61,128) 315,988
Payables for business acquisitions 7,813 8,604 - - 16,417
Contract liabilities 90,759 15,749 7,984 - 114,492
Other payables and tax payables 227,753 23,376 27,329 (196) 278,262
Hedging instruments 266 - - - 266
Provisions for risks and charges 1,685 710 - - 2,395
Liabilities for employees' benefits 841 449 2,464 - 3,754
Short-term financial liabilities 256,117
Lease liabilities 77,062 8,876 19,602 - 105,540
Total current liabilities 1,093,231
TOTAL LIABILITIES 3,565,584

(*) The items in the statement of financial position are analyzed by the CEO and Top Management by geographic area without being separated from the Corporate functions which are included in EMEA.

Statement of Financial Position as at December 31st, 2022 (*)

(€ thousands) EMEA AMERICAS APAC ELIM. CONSOLIDATED
ASSETS
Non-current assets
Goodwill 921,163 213,816 619,049 - 1,754,028
Intangible fixed assets with finite useful life 298,642 53,903 67,553 - 420,098
Property, plant, and equipment 136,721 21,006 35,688 - 193,415
Right-of-use assets 366,243 34,242 51,262 - 451,747
Equity-accounted investments 2,093 - - - 2,093
Hedging instruments 25,850 - - - 25,850
Deferred tax assets 60,867 10,206 10,707 - 81,780
Deferred contract costs 9,841 1,206 84 - 11,131
Other assets 30,361 10,494 1,615 - 42,470
Total non-current assets 2,982,612
Current assets
Inventories 60,417 5,781 10,060 - 76,258
Receivables 270,798 54,107 33,985 (94,213) 264,677
Deferred contract costs 4,437 744 81 - 5,262
Hedging instruments 17,016 - - - 17,016
Other financial assets 49,986
Cash and cash equivalents 179,654
Total current assets 592,853
TOTAL ASSETS 3,575,465
LIABILITIES
Net Equity 1,040,350
Non-current liabilities
Medium/long-term financial liabilities 798,940
Lease liabilities 304,182 28,995 35,713 - 368,890
Provisions for risks and charges 17,712 787 1,445 - 19,944
Liabilities for employees' benefits 8,023 203 714 - 8,940
Hedging instruments - - - - -
Deferred tax liabilities 61,419 26,053 19,211 - 106,683
Payables for business acquisitions 3,209 2,496 - - 5,705
Contract liabilities 136,574 14,744 2,295 - 153,613
Other long-term liabilities 15,149 974 - - 16,123
Total non-current liabilities 1,478,838
Current assets
Trade payables 310,412 68,611 40,574 (94,014) 325,583
Payables for business acquisitions 7,585 17,016 - - 24,601
Contract liabilities 91,613 15,034 8,210 - 114,857
Other payables and tax payables 192,769 19,919 30,092 (199) 242,581
Hedging instruments - - - - -
Provisions for risks and charges 975 688 - - 1,663
Liabilities for employees' benefits 789 393 2,434 - 3,616
Short-term financial liabilities 243,661
Lease liabilities 73,798 7,827 18,090 - 99,716
Total current liabilities 1,056,277
TOTAL LIABILITIES 3,575,465

(*) The items in the statement of financial position are analyzed by the CEO and Top Management by geographic area without being separated from the Corporate functions which are included in EMEA.

Income Statement – First three months 2023 (*)

(€ thousands) EMEA AMERICAS APAC CORPORATE ELIM. CONSOLIDATED
Revenues from sales and services 359,707 100,864 79,594 86 - 540,251
Operating costs (261,166) (78,355) (57,951) (30,490) - (427,962)
Other income and costs 883 2,322 98 49 - 3,352
Gross operating profit by segment
(EBITDA)
99,424 24,831 21,741 (30,355) - 115,641
Amortization, depreciation and
impairment
Intangible assets amortization
(10,028) (2,474) (3,761) (4,721) - (20,984)
Property, plant, and equipment
depreciation (8,034) (1,558) (2,656) (686) - (12,934)
Right-of-use depreciation (18,932) (2,671) (5,969) (565) - (28,137)
Impairment losses and reversals of non
current assets
(22) - 2 - - (20)
(37,016) (6,703) (12,384) (5,972) - (62,075)
Operating result by segment 62,408 18,128 9,357 (36,327) - 53,566
Financial income, expenses and value
adjustments to financial assets
Group's share of the result of associated
companies valued at equity and
gains/losses on disposals of equity
126 - - - - 126
investments
Interest income and expenses (5,952)
Interest expenses on lease liabilities (3,263)
Other financial income and expenses (1,202)
Exchange gains and losses, and inflation
accounting
(1,978)
Gain (loss) on assets accounted at fair
value
321
(11,948)
Net profit (loss) before tax 41,618
Current and deferred income tax
Current income tax (18,751)
Deferred tax 6,392
(12,359)
Net profit (loss) 29,259
Net profit (loss) attributable to Minority
interests
(40)
Net profit (loss) attributable to the
Group
29,299

(*) The figures of the operating segments are net of the intercompany eliminations.

Income Statement – First three months 2022 (*)

(€ thousands) EMEA AMERICAS APAC CORPORATE ELIM. CONSOLIDATED
Revenues from sales and services 340,172 84,021 71,462 153 - 495,808
Operating costs (248,744) (63,357) (53,090) (22,323) - (387,514)
Other income and costs 982 6 (41) 565 - 1,512
Gross operating profit by segment
(EBITDA)
92,410 20,670 18,331 (21,605) - 109,806
Amortization, depreciation and
impairment
Intangible assets amortization (8,952) (2,287) (4,160) (3,711) - (19,110)
Property, plant, and equipment
depreciation
(8,389) (963) (2,308) (711) - (12,371)
Right-of-use depreciation (18,655) (1,897) (5,004) (561) - (26,117)
Impairment losses and reversals of non
current assets
(99) 60 (12) - - (51)
(36,095) (5,087) (11,484) (4,983) - (57,649)
Operating result by segment 56,315 15,583 6,847 (26,588) - 52,157
Financial income, expenses and value
adjustments to financial assets
Group's share of the result of associated
companies valued at equity and
gains/losses on disposals of equity
investments
49 - - - - 49
Interest income and expenses (4,661)
Interest expenses on lease liabilities (2,736)
Other financial income and expenses (**) (447)
Exchange gains and losses, and inflation
accounting (**)
1,043
Gain (loss) on assets accounted at fair
value (**)
(1,692)
(8,444)
Net profit (loss) before tax 43,713
Current and deferred income tax
Current income tax (16,510)
Deferred tax 3,484
(13,026)
Net profit (loss) 30,687
Net profit (loss) attributable to Minority
interests
74

Net profit (loss) attributable to the Group 30,613

(*) The figures of the operating segments are net of the intercompany eliminations.

(**) It is specified that, on the comparative period 2022, reclassifications between "Financial income, expenses and value adjustments to financial assets" have been made in order to better represent financial information.

22. Accounting policies

22.1 Presentation of financial statements

The Interim Financial Report as at 31 March 2023 was prepared in accordance with the historical cost method with the exception of derivatives, a few financial investments measured at fair value and assets and liabilities hedged against changes in fair value, as explained in more detail in this report, as well as on a going concern basis.

With regard to the financial statements, the following is specified:

  • in the statement of financial position, the Group distinguishes between non-current and current assets and liabilities;
  • in the income statement, the Group classifies costs by nature insofar as this is deemed to provide a more accurate representation of the Group's primarily commercial and distribution activities;
  • comprehensive income statement: in addition to the net result for the year, it includes the impact of differences in exchange rates, the cash flow hedge reserve, the foreign currency basis spread reserve for derivatives, as well as the actuarial gains and losses that have been recognized directly in changes in shareholders' equity, these items are divided according to whether or not they can be subsequently reclassified to the income statement
  • statement of changes in net equity: the Group reports all the changes in net equity, including those deriving from shareholder transactions (payment of dividends and capital increases);
  • statement of cash flows: is prepared using the indirect method to determine cash flow from operations.

22.2 Use of estimates in preparing the financial statements

The preparation of the financial statements and explanatory notes requires the use of estimates and assumptions particularly with regard to the following items:

  • revenues for services rendered over time recognized based on the input or output needed to satisfy the performance obligation;
  • allowances for impairment made based on the asset's estimated realizable value;
  • provisions for risks and charges made based on a reasonable estimate of the amount of the potential liability, including with regard to any counterparty claims;
  • provisions for obsolete inventories in order to align the carrying value of inventories with the estimated realizable value;
  • provisions for employee benefits, calculated based on actuarial valuations;
  • amortization and depreciation of intangible assets, tangible fixed assets and right of use assets recognized based on the estimated remaining useful life and the recoverable amount;
  • income tax recognized based on the best estimate of the tax rate for the full year;
  • IRSs and currency swaps (instruments not traded on regulated markets), marked to market at the reporting date based on the yield curve and market exchange rates, which are subject to credit/debit valuation adjustments based on market prices;
  • the lease term duration was determined on a lease-by-lease basis and is comprised of the "non-cancellable" period along with the impact of any extension or early termination clauses

if exercise of that clause is reasonably certain and taking into account any and all lease clauses;

  • discount rate of leases falling within the scope of IFRS 16 (incremental borrowing rate) determined based on the IRS (reference interbank rate used as an index for fixed-rate mortgage loans) in the individual countries in which Amplifon Group companies operate, for maturities commensurate with the duration of the specific rental agreement, plus the Parent Company's credit spread and any costs for additional guarantees. In the rare instances when the IRS rate is not available (Egypt, Ecuador, Mexico and Panama), the risk-free rate was determined based on government bonds with maturities similar to the duration of the specific rental agreement.

Estimates are periodically reviewed, and any changes made, following the change of the circumstances based on which the estimates were made or the availability of better information, are recognized in the income statement. The use of reasonable estimates is essential to the preparation of the financial statements and does not affect their overall reliability.

The Group verifies the existence of a loss in value of goodwill regularly, once a year or in the event of impairment indicators. This calls for an estimate of the value in use of the cash generating units to which the goodwill refers based on an estimate of future cash flows and the after-tax discount rate which reflects market conditions at the valuation date.

22.3 IFRS standards/interpretations approved by the IASB and endorsed in Europe

The following table lists the IFRS/interpretations approved by the IASB, endorsed in Europe and applied for the first time this year.

Description Endorsement
date
Publication in
the G.U.C.E.
Effective date Effective date for
Amplifon
Amendment to IAS 1 "Presentation of
Financial Statements" e IFRS Practice
Statement 2: Disclosure of Accounting
Policies (issued on 12 February 2021)
2 Mar '22 3 Mar '22 1 Jan '23 1 Jan '23
IFRS 17 "Insurance Contracts" (issued
on 18 May 2017); including
amendments to IFRS 17 (issued on 25
June 2020)
19 Nov '21 23 Nov '21 1 Jan '23 1 Jan '23
Amendment to IFRS 17 "Insurance
contracts" and IFRS 9 (issued on 9
December 2021)
8 Sept '22 9 Set '22 1 Jan '23 1 Jan '23
Amendment to IAS 12 "Income Taxes:
Deferred Tax related to Assets and
Liabilities arising from a Single
Transaction (issued on 7 May 2021)
11 Aug '22 12 Aug '22 1 Jan '23 1 Jan '23
Amendment to IAS 8 "Accounting
policies, Changes in Accounting
Estimates and Errors: Definition of
Accounting Estimates" (issued on 12
February 2021)
2 Mar '22 3 Mar '22 1 Jan '23 1 Jan '23

Amendments to IAS 1 "Presentation of Financial Statements" and "IFRS Practice Statement 2 Disclosure of Accounting Policies" which strive to improve accounting policy disclosures, in order to provide investors and other primary users of the financial statements with more useful information, as well as help companies clarify the distinction between changes in accounting policies and changes in accounting estimates.

IFRS 17 "Insurance Contracts" is a new standard which relates to the recognition and measurement, presentation and disclosure of insurance contracts which will substitute IFRS 4, issued in 2005. This standard is applicable to all types of insurance contracts, regardless of the issuer, as well as to a few guarantees and financial instruments with discretionary participation features.

Amendments to IAS 12 "Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Transaction" calls for exceptions to the "initial recognition exemption" provided

in IAS 12.25 (b) and IAS 12.24. The provision impacts the calculation of the tax liability recorded upon "initial recognition".

Amendments to IAS 8 ''Accounting policies, Changes in Accounting Estimates and Errors'' which allow the entities to distinguish between accounting principle and accounting estimates through the introduction of a new definition of ''accounting estimates''.

The adoption of the above standards and interpretations is not expected to have a material impact on the measurement of the Group's assets, liabilities, costs and revenues.

22.4 Future accounting standards and interpretations

IFRS standards/interpretations approved by IASB, but not endorsed in Europe

The following are the international accounting standards, interpretations, amendments to existing accounting standards and interpretations, or specific provisions contained in the standards and interpretations approved by the IASB which, at 5 April 2023, had yet to be endorsed for adoption in Europe.

Description Expected effective date
Amendments to IAS 1: "Presentation of Financial Statements – Classification of
liabilities as current or non-current" and "Classification of Liabilities as Current or
Non-current - Deferral of Effective Date" and ''Non-current Liabilities with Periods beginning on or after
Covenants'' 1 Jan '24
(issued on 23 January 2020, 15 July 2020 and 31 October 2022, respectively)
Amendments to IFRS 16 "Leases: Lease Liability in a Sale and Leaseback" (issued Periods beginning on or after
on September 22 2022) 1 Jan '24

IAS 1 amendments are related to the definitions of current and non-current assets, providing a more generalized approach to the classification of liabilities under the standard, based on the contractual agreements.

IFRS 16 amendments are related to the definitions of liabilities derived from leasebacks and the accounting treatment of any gains or losses stemming from these transactions.

The adoption of the standards and interpretations above is not expected to have a material impact on the measurement of the Group's assets, liabilities, costs and revenues.

23. Subsequent events

After 31 March 2023, the exercise of the performance stock grants continued, and the beneficiaries received a total of 7,285 treasury shares from the Company. At the date of this report, the Company has a total of 1,798,450 treasury shares or 0.794% of its share capital.

The Group's external growth continued in April 2023 with the acquisition of a total of 28 stores in China, Poland and France.

Milan, May 2nd, 2023

CEO

Enrico Vita

Annexes

Annex I

Consolidation scope

As required by articles 38 and 39 of Law 127/91 and article 126 of Consob's resolution 11971 dated 14 May 1999, as amended by resolution 12475 dated 6 April 2000, the following is the list of companies included in the consolidation scope of Amplifon S.p.A. at 31 March 2023.

Parent company:

Company name Head office Currency Share capital
Amplifon S.p.A. Milan (Italy) EUR 4,527,772

Subsidiaries consolidated using the line-by-line method:

Company name Head office Direct/Indirect
ownership
Currency Share Capital % held as at
03/31/2023
Amplifon Italia S.p.A Milan (Italy) D EUR 100,000 100.0%
Amplifon Rete Milan (Italy) I EUR 19,250 2.6%
Audibel S.r.l (in liquidazione) Rome (Italy) D EUR 70,000 100.0%
Pilot Blankenfelde Medizinisch
Elektronische Gerate GmbH
Blankenfelde-Mahlow
(Germany)
D EUR 34,595 100.0%
Amplifon France SAS Arcueil (France) D EUR 98,550,898 100.0%
SCI Eliot Leslie Lyon (France) I EUR 610 100.0%
Amplifon France Holding Arcueil (France) D EUR 1 100.0%
Audition Nouvelle Versailles (France) I EUR 10,000 100.0%
Audition Frederic Rembaud Périgueux (France) I EUR 40,000 100.0%
Audition 50 Granville (France) I EUR 40,000 100.0%
Audition Marquilly Lavelanet (France) I EUR 15,000 100.0%
Surdité Toulorge Cherbourg (France) I EUR 3,920 100.0%
NewEar Guidel (France) I EUR 502,830 100.0%
Ghama Guidel (France) I EUR 5,000 100.0%
Adagio Guidel (France) I EUR 14,000 100.0%
Audition Guidel Guidel (France) I EUR 1,500 100.0%
Octave Audition Moret Loing et
Orvanne (France)
I EUR 10,000 100.0%
Argenteuil Acoustique Médicale Argenteuil (France) I EUR 13,000 100.0%
SAS Galy Fronton (France) I EUR 5,000 100.0%
Amplifon Iberica SA Barcelona (Spain) D EUR 26,578,809 100.0%
Microson S.A. Barcelona (Spain) D EUR 61,752 100.0%
Amplifon LATAM Holding S.L. Barcelona (Spain) I EUR 3,000 100.0%
Amplifon Portugal SA Lisboa (Portugal) I EUR 15,520,187 100.0%
Amplifon Magyarország Kft Budapest (Hungary) D HUF 723,500,000 100.0%
Amplibus Magyarország Kft Budaörs (Hungary) I HUF 3,000,000 100.0%
Amplifon AG Baar (Switzerland) D CHF 1,000,000 100.0%
Company name Head office Direct/Indirect
ownership
Currency Share Capital % held as at
03/31/2023
Amplifon Nederland BV Doesburg (The
Netherlands)
D EUR 74,212,052 100.0%
Auditech BV Doesburg (The
Netherlands)
I EUR 22,500 100.0%
Electro Medical Instruments BV Doesburg (The
Netherlands)
I EUR 16,650 100.0%
Beter Horen BV Doesburg (The
Netherlands)
I EUR 18,000 100.0%
Amplifon Customer Care Service BV Elst (The Netherlands) I EUR 18,000 100.0%
Amplifon Belgium NV Bruxelles (Belgium) D EUR 495,800 100.0%
Amplifon RE SA Luxembourg
(Luxembourg)
D EUR 3,700,000 100.0%
Amplifon Deutschland GmbH Hamburg (Germany) D EUR 6,026,000 100.0%
Focus Hören AG Willroth (Germany) I EUR 485,555 100.0%
Focus Hören Deutschland GmbH Willroth (Germany) I EUR 25,000 100.0%
Amplifon Poland Sp. z o.o. Lodz (Poland) D PLN 3,346,400 100.0%
Audiomed Sp.z.o.o. Varsavia (Poland) I PLN 5,000 100.0%
Amplifon UK Ltd Manchester (United
Kingdom)
D GBP 130,951,168 100.0%
Amplifon Ltd Manchester (United
Kingdom)
I GBP 1,800,000 100.0%
Ultra Finance Ltd Manchester (United
Kingdom)
I GBP 75 100.0%
Amplifon Cell Ta' Xbiex (Malta) D EUR 2,500,125 100.0%
Medtechnica Ortophone Ltd (*) Tel Aviv (Israel) D ILS 1,100 80.0%
Amplifon Middle East SAE Cairo (Egypt) D EGP 3,000,000 51.0%
Miracle Ear Inc. St. Paul (United States) I USD 5 100.0%
Elite Hearing, LLC Minneapolis (United
States)
I USD 1,000 100.0%
Amplifon USA Inc. Dover (United States) D USD 52,500,010 100.0%
Amplifon Hearing Health Care. Inc. St. Paul (United States) I USD 10 100.0%
Ampifon IPA, LLC New York (United
States)
I USD - 100.0%
ME Pivot Holdings, LLC Minneapolis (United
States)
I USD 2,000,000 100.0%
ME Flagship, LLC Wilmington (United
States)
I USD - 100.0%
METX, LLC Waco (United States) I USD - 100.0%
MEFL, LLC Waco (United States) I USD - 100.0%
METAMPA, LLC Waco (United States) I USD - 100.0%
MENM, LLC Waco (United States) I USD - 100.0%
MEOH, LLC Minneapolis (United
States)
I USD - 100.0%
Miracle Ear Canada Ltd. Vancouver (Canada) I CAD 80,201,200 100.0%
2829663 Ontario Inc Milton (Canada) I CAD - 100.0%
Ossicle Fort McMurray Inc Fort McMurray
(Canada)
I CAD - 100.0%
Southern Alberta Hearing Aid Ltd Lethbridge (Canada) I CAD - 100.0%
Burnaby Hearing Center Inc Burnaby (Canada) I CAD - 100.0%
Raindrop Hearing Clinici Inc Toronto (Canada) I CAD - 100.0%
Terrace Hearing Clinic Ltd. Terrace (Canada) I CAD - 100.0%
The Hearing Clinic Scarborough (Canada) I CAD - 100.0%

Interim Financial Report as at 31 March 2023 > Condensed Consolidated Financial Statements

Company name Head office Direct/Indirect
ownership
Currency Share Capital % held as at
03/31/2023
Lisa Reid Audiology Hearing Centres Manitoba (Canada) I CAD - 100.0%
Great to Hear, Inc Manitoba (Canada) I CAD 35 100.0%
Ontario, Inc Ontario (Canada) I CAD 1,000,100 100.0%
Living Sounds Hearing Centre Ltd. Alberta (Canada) I CAD 100 100.0%
Professional Hearing Services
Ltd./100391416 Ontario Ltd.
Ontario (Canada) I CAD 1,210 100.0%
Sackville Hearing Centre Limited Nova Scotia (Canada) I CAD 1,020 100.0%
GAES S.A. Santiago de Chile
(Chile)
I CLP 1,901,686,034 100.0%
GAES Servicios Corporativo de
Latinoamerica Spa
Santiago de Chile
(Chile)
I CLP 10,000,000 100.0%
Audiosonic Chile S.A. Santiago de Chile
(Chile)
I CLP 1,000,000 99.0%
GAES S.A. Buenos Aires
(Argentina)
I ARS 120,542,331 100.0%
GAES Colombia SAS Bogotà (Colombia) I COP 21,900,000,000 100.0%
Audiovital S.A. Quito (Ecuador) I USD 430,337 100.0%
Centros Auditivos GAES Mexico sa de
cv
Ciudad de México
(Mexico)
I MXN 194,683,815 100.0%
Compañía de Audiologia y Servicios
Medicos sa de cv
Aguascalientes
(Mexico)
I MXN 43,306,212 100.0%
GAES Panama S.A. Panama (Panama) I PAB 510,000 100.0%
Amplifon Australia Holding Pty Ltd Sydney (Australia) D AUD 392,000,000 100.0%
National Hearing Centres Pty Ltd Sydney (Australia) I AUD 100 100.0%
National Hearing Centres Unit Trust Sydney (Australia) I AUD - 100.0%
Attune Hearing Pty Ltd Brisbane (Australia) D AUD 14,771,093 100.0%
Attune Workplace Hearing Pty Ltd Brisbane (Australia) I AUD 1 100.0%
Ear Deals Pty Ltd Brisbane (Australia) I AUD 300,000 100.0%
Otohub Unit Trust (in liquidazione) Brisbane (Australia) D AUD - 100.0%
Otohub Australasia Pty Ltd Brisbane (Australia) D AUD 10 100.0%
Bay Audio Pty Ltd Sydney (Australia) D AUD 10,000 100.0%
Amplifon Asia Pacific Pte Limited Singapore (Singapore) I SGD 1,000,000 100.0%
Amplifon NZ Ltd Takapuna (New
Zealand)
I NZD 130,411,317 100.0%
Bay Audiology Ltd Takapuna (New
Zealand)
I NZD - 100.0%
Dilworth Hearing Ltd Auckland (New
Zealand)
I NZD - 100.0%
Auckland Hearing Ltd Auckland (New
Zealand)
I NZD - 100.0%
Amplifon India Pvt Ltd Gurgaon (India) I INR 1,770,000,000 100.0%
Beijing Amplifon Hearing Technology
Center Co. Ltd
Běijīng (China) D CNY 2,143,685 100.0%
Tianjin Amplifon Hearing Technology
Co. Ltd
Tianjin (China) I CNY 3,500,000 100.0%
Shijiazhuang Amplifon Hearing
Technology Co. Ltd
Shijiazhuang (China) I CNY 100,000 100.0%
Shanghai Amplifon Hearing Aid Co.
Ltd
Shanghai (China) D CNY 46,000,000 100.0%
Hangzhou Amplifon Hearing Aid Co.
Ltd (**)
Hangzhou (China) D CNY 11,000,000 60.0%
Zhengzhou Yuanjin Hearing
Technology Co Ltd. (**)
Zhengzhou (China) I CNY - 60.0%
Wuhan Amplifon Hearing Aids Co.
Ltd
Wuhan (China) I CNY 1,250,000 100.0%
Company name Head office Direct/Indirect
ownership
Currency Share Capital % held as at
03/31/2023
Shanghai Amplifon Hearing
Technology Co. Ltd
Shanghai (China) I CNY 100,000 100.0%
Nanjing Amplifon Hearing Aid Co. Ltd Nanjing (China) I CNY 100,000 100.0%
Shanxi Tingdaoai Hearing Technology
Co.Ltd
Taiyuan (China) I CNY 3,000,000 100.0%

(*) Medtechnica Ortophone Ltd, despite being 80% owned by Amplifon, is consolidated at 100% without exposure of non-controlling interests due to the put-call option exercisable from 2019 and related to the purchase of the remaining 20%.

(**) Hangzhou Amplifon Hearing Aid Co.. Ltd. And its subsidiary Zhengzhou Yuanjin Hearing Technology Co. Ltd (together Soundbridge) are consolidated using the full consolidation method, with a control of the group of 60% because of the direct ownership of 51% and a put-call option for an additional 9%.

Companies valued using the equity method:

Company name Head office Direct/Indirect
ownership
Currency Share
Capital
% held as at
03/31/2023
Comfoor BV (*) Doesburg (The
Netherlands)
I EUR 18,000 50.0%
Comfoor GmbH (*) Emmerich am Rhein
(Germany)
I EUR 25,000 50.0%
Ruti Levinson Institute Ltd (**) Ramat HaSharon
(Israel)
I ILS 105 16.0%
Afik - Test Diagnosis & Hearing Aids
Ltd (**)
Jerusalem (Israel) I ILS 100 16.0%
Lakeside Specialist Centre Ltd (**) Mairangi Bay (New
Zealand)
I NZD - 50.0%

(*) Joint Venture

(**) Related companies

Declaration of the Executive Responsible for Corporate Accounting Information pursuant to Article 154-bis of Legislative Decree 58/1998 (Consolidated finance act)

I, the undersigned, Gabriele Galli, Chief Financial Officer of Amplifon Group, Executive Responsible for Accounting Information, declare that the consolidated financial statements as at 31 March 2023 correspond to documented results, books, and accounting entries.

Milan, May 2nd, 2023

Executive Responsible for Corporate Accounting Information

Gabriele Galli